Interstitial	O
deletion	O
constitutes	O
the	O
major	O
mechanism	O
for	O
loss	O
of	O
heterozygosity	O
on	O
chromosome	B-DNA
20q	I-DNA
in	O
polycythemia	O
vera	O
.	O

An	O
acquired	O
deletion	O
of	O
the	O
long	O
arm	O
of	O
chromosome	B-DNA
20	I-DNA
is	O
a	O
recurrent	O
abnormality	O
in	O
myeloproliferative	O
disorders	O
,	O
particularly	O
polycythemia	O
vera	O
and	O
myelodysplastic	O
syndromes	O
.	O

The	O
association	O
of	O
20q	B-DNA
deletions	I-DNA
with	O
myeloid	O
``	O
stem	O
cell	O
''	O
disorders	O
suggests	O
that	O
the	O
deletions	O
mark	O
the	O
site	O
of	O
one	O
or	O
more	O
genes	O
,	O
loss	O
or	O
inactivation	O
of	O
which	O
plays	O
a	O
role	O
in	O
the	O
regulation	O
of	O
normal	B-cell_type
hematopoietic	I-cell_type
progenitors	I-cell_type
.	O

We	O
have	O
recently	O
performed	O
a	O
detailed	O
molecular	O
analysis	O
of	O
20q	B-DNA
deletions	I-DNA
in	O
peripheral	B-cell_type
blood	I-cell_type
(	I-cell_type
PB	I-cell_type
)	I-cell_type
granulocytes	I-cell_type
and	O
defined	O
a	O
commonly	B-DNA
deleted	I-DNA
region	I-DNA
of	O
16	O
to	O
21	O
centimorgan	O
(	O
cM	O
)	O
.	O

To	O
further	O
reduce	O
the	O
size	O
of	O
the	O
common	O
deleted	O
region	O
we	O
have	O
searched	O
for	O
small	O
deletions	O
or	O
mitotic	O
recombination	O
events	O
,	O
neither	O
of	O
which	O
would	O
be	O
detected	O
by	O
conventional	O
cytogenetics	O
.	O

We	O
have	O
studied	O
48	O
patients	O
with	O
polycythemia	O
vera	O
and	O
four	O
patients	O
with	O
idiopathic	O
myelofibrosis	O
.	O

In	O
each	O
case	O
,	O
cytogenetic	O
analysis	O
had	O
either	O
failed	O
or	O
had	O
shown	O
no	O
abnormalities	O
of	O
chromosome	B-DNA
20	I-DNA
.	O

Seventeen	O
microsatellite	B-DNA
markers	I-DNA
that	O
span	O
the	O
common	O
deleted	O
region	O
were	O
used	O
to	O
search	O
for	O
loss	O
of	O
heterozygosity	O
in	O
granulocyte	B-DNA
DNA	I-DNA
.	O

No	O
instance	O
of	O
microsatellite	O
instability	O
was	O
observed	O
in	O
a	O
total	O
of	O
880	O
comparisons	O
of	O
granulocyte	B-DNA
and	I-DNA
T-cell	I-DNA
DNA	I-DNA
.	O

Granulocyte	O
DNA	O
from	O
four	O
patients	O
exhibited	O
allele	O
loss	O
on	O
20q	B-DNA
.	O

In	O
each	O
case	O
the	O
allele	O
loss	O
was	O
caused	O
by	O
an	O
interstitial	O
deletion	O
because	O
heterozygosity	O
at	O
distal	B-DNA
markers	I-DNA
was	O
retained	O
and	O
because	O
quantitative	O
Southern	O
blotting	O
demonstrated	O
hemizygosity	O
.	O

Loss	O
of	O
heterozygosity	O
in	O
PB	B-cell_type
granulocytes	I-cell_type
would	O
be	O
masked	O
by	O
the	O
presence	O
of	O
significant	O
numbers	O
of	O
normal	B-cell_type
granulocytes	I-cell_type
not	O
derived	O
from	O
the	O
malignant	B-cell_line
clone	I-cell_line
.	O

Therefore	O
,	O
the	O
human	B-protein
androgen	I-protein
receptor	I-protein
assay	O
(	O
HUMARA	O
)	O
was	O
used	O
to	O
determine	O
granulocyte	O
clonality	O
.	O

In	O
21	O
of	O
27	O
informative	O
female	O
patients	O
the	O
majority	O
of	O
the	O
granulocytes	B-cell_type
were	O
clonally	O
derived	O
.	O

In	O
5	O
patients	O
the	O
granulocytes	B-cell_type
appeared	O
polyclonal	O
and	O
in	O
1	O
patient	O
unilateral	O
X	O
inactivation	O
was	O
observed	O
in	O
both	O
granulocytes	B-cell_type
and	O
T	B-cell_type
cells	I-cell_type
.	O

These	O
results	O
show	O
that	O
,	O
in	O
the	O
vast	O
majority	O
of	O
patients	O
presented	O
here	O
,	O
the	O
failure	O
to	O
detect	O
loss	O
of	O
heterozygosity	O
can	O
not	O
be	O
attributed	O
to	O
the	O
presence	O
of	O
normal	B-cell_line
polyclonal	I-cell_line
granulocytes	I-cell_line
.	O

Our	O
results	O
therefore	O
show	O
that	O
allele	O
loss	O
on	O
chromosome	B-DNA
20q	I-DNA
in	O
polycythemia	O
vera	O
does	O
not	O
commonly	O
involve	O
mitotic	O
recombination	O
or	O
chromosome	B-DNA
loss	O
and	O
that	O
microsatellite	O
instability	O
is	O
a	O
rare	O
event	O
in	O
this	O
disorder	O
.	O

Interstitial	NULL
Deletion	NULL
Constitutes	NULL
the	NULL
Major	NULL
Mechanism	NULL
for	NULL
Loss	NULL
of	NULL
Heterozygosity	NULL
on	NULL
Chromosome	NULL
20q	NULL
in	NULL
Polycythemia	NULL
Vera	NULL
By	NULL
Fotios	NULL
A.	NULL
Asimakopoutos	NULL
,	NULL
James	NULL
G.R	NULL
.	NULL

Gilbert	NULL
,	NULL
Micheala	NULL
A.	NULL
Aldred	NULL
,	NULL
Thomas	NULL
C.	NULL
Pearson	NULL
,	NULL
and	NULL
Anthony	NULL
R.	NULL
Green	NULL
An	NULL
acquired	NULL
deletion	NULL
of	NULL
the	NULL
long	NULL
arm	NULL
of	NULL
chromosome	NULL
20	NULL
is	NULL
a	NULL
recurrent	NULL
abnormality	NULL
in	NULL
myeloproliferative	NULL
disorders	NULL
,	NULL
particularly	NULL
polycythemia	NULL
vera	NULL
and	NULL
myelodysplastic	NULL
syndromes	NULL
.	NULL

The	NULL
association	NULL
of	NULL
20q	NULL
deletions	NULL
with	NULL
myeloid	NULL
``	NULL
stem	NULL
cell	NULL
``	NULL
disorders	NULL
suggests	NULL
that	NULL
the	NULL
deletions	NULL
mark	NULL
the	NULL
site	NULL
of	NULL
one	NULL
or	NULL
more	NULL
genes	NULL
,	NULL
loss	NULL
or	NULL
inactivation	NULL
of	NULL
which	NULL
plays	NULL
a	NULL
role	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
normal	NULL
hematopoietic	NULL
progenitors	NULL
.	NULL

We	NULL
have	NULL
recently	NULL
performed	NULL
a	NULL
detailed	NULL
molecular	NULL
analysis	NULL
of	NULL
20q	NULL
deletions	NULL
in	NULL
peripheral	NULL
blood	NULL
(	NULL
PB	NULL
)	NULL
granulocytes	NULL
and	NULL
defined	NULL
a	NULL
commonly	NULL
deleted	NULL
region	NULL
of	NULL
16	NULL
to	NULL
21	NULL
centimorgan	NULL
(	NULL
cM	NULL
}	NULL
.	NULL

To	NULL
further	NULL
reduce	NULL
the	NULL
size	NULL
of	NULL
the	NULL
common	NULL
deleted	NULL
region	NULL
we	NULL
have	NULL
searched	NULL
for	NULL
small	NULL
deletions	NULL
or	NULL
mitotic	NULL
recombination	NULL
events	NULL
,	NULL
neither	NULL
of	NULL
which	NULL
would	NULL
be	NULL
detected	NULL
by	NULL
conventional	NULL
cytogenetics	NULL
.	NULL

We	NULL
have	NULL
studied	NULL
48	NULL
patients	NULL
with	NULL
polycythemia	NULL
vera	NULL
and	NULL
four	NULL
patients	NULL
with	NULL
idiopathic	NULL
myelofibrosis	NULL
.	NULL

In	NULL
each	NULL
case	NULL
,	NULL
cytogenetic	NULL
analysis	NULL
had	NULL
either	NULL
failed	NULL
or	NULL
had	NULL
shown	NULL
no	NULL
abnormalities	NULL
of	NULL
chromosome	NULL
20	NULL
.	NULL

Seventeen	NULL
microsatellite	NULL
markers	NULL
that	NULL
span	NULL
the	NULL
common	NULL
deleted	NULL
region	NULL
were	NULL
used	NULL
to	NULL
search	NULL
for	NULL
loss	NULL
of	NULL
heterozygosity	NULL
in	NULL
granulocyte	NULL
DNA	NULL
.	NULL

No	NULL
instance	NULL
of	NULL
microsatellite	NULL
instability	NULL
was	NULL
observed	NULL
in	NULL
a	NULL
total	NULL
of	NULL
880	NULL
comparisons	NULL
of	NULL
granulocyte	NULL
and	NULL
T-cell	NULL
DNA	NULL
.	NULL

Granulocyte	NULL
DNA	NULL
from	NULL
four	NULL
patients	NULL
exhib-	NULL
CQUIRED	NULL
DELETIONS	NULL
of	NULL
the	NULL
long	NULL
arm	NULL
of	NULL
chromosome	NULL
20	NULL
are	NULL
a	NULL
recurring	NULL
abnormality	NULL
in	NULL
myeloid	NULL
hematologic	NULL
disorders	NULL
.	NULL

They	NULL
were	NULL
originally	NULL
described	NULL
in	NULL
polycythemia	NULL
vera	NULL
(	NULL
PV	NULL
)	NULL
'	NULL
and	NULL
they	NULL
represent	NULL
the	NULL
most	NULL
common	NULL
chromosomal	NULL
abnormality	NULL
associated	NULL
with	NULL
this	NULL
disorder	NULL
.	NULL
``	NULL

However	NULL
,	NULL
20q	NULL
deletions	NULL
are	NULL
also	NULL
found	NULL
in	NULL
other	NULL
myeloproliferative	NULL
disorders	NULL
,	NULL
``	NULL
the	NULL
myelodysplastic	NULL
syndromes	NULL
and	NULL
acute	NULL
myeloid	NULL
leukemia	NULL
(	NULL
AML	NULL
)	NULL
,	NULL
Â°*	NULL
but	NULL
typically	NULL
at	NULL
lower	NULL
rates	NULL
than	NULL
in	NULL
polycythemia	NULL
.	NULL

They	NULL
are	NULL
rarely	NULL
reported	NULL
in	NULL
association	NULL
with	NULL
lymphoid	NULL
malignancies	NULL
.	NULL
``	NULL

This	NULL
pattern	NULL
of	NULL
disease	NULL
association	NULL
implies	NULL
that	NULL
20q	NULL
deletions	NULL
mark	NULL
the	NULL
site	NULL
of	NULL
one	NULL
or	NULL
more	NULL
genes	NULL
,	NULL
loss	NULL
or	NULL
inactivation	NULL
of	NULL
which	NULL
contributes	NULL
to	NULL
the	NULL
dysregulation	NULL
of	NULL
hematopoietic	NULL
progenitors	NULL
.	NULL

We	NULL
recently	NULL
performed	NULL
a	NULL
detailed	NULL
cytogenetic	NULL
and	NULL
molecular	NULL
analysis	NULL
of	NULL
20q	NULL
deletions	NULL
.	NULL
``	NULL

Our	NULL
data	NULL
showed	NULL
two	NULL
classes	NULL
of	NULL
deletions	NULL
:	NULL
large	NULL
deletions	NULL
encompassing	NULL
both	NULL
Giemsa	NULL
positive	NULL
[	NULL
G	NULL
(	NULL
+	NULL
)	NULL
]	NULL
bands	NULL
on	NULL
20q	NULL
and	NULL
small	NULL
deletions	NULL
encompassing	NULL
only	NULL
one	NULL
G	NULL
(	NULL
+	NULL
)	NULL
band	NULL
.	NULL

Reverse	NULL
chromosome	NULL
painting	NULL
was	NULL
used	NULL
to	NULL
show	NULL
that	NULL
the	NULL
cytogenetic	NULL
common	NULL
deleted	NULL
region	NULL
From	NULL
the	NULL
Department	NULL
of	NULL
Haematology	NULL
,	NULL
University	NULL
of	NULL
Cambridge	NULL
,	NULL
MRC	NULL
Centre	NULL
,	NULL
Cambridge	NULL
;	NULL
and	NULL
the	NULL
Department	NULL
of	NULL
Haematology	NULL
,	NULL
United	NULL
Medical	NULL
and	NULL
Dental	NULL
Schools	NULL
,	NULL
St	NULL
Thomas	NULL
's	NULL
Hospital	NULL
,	NULL
London	NULL
,	NULL
UK	NULL
.	NULL

Submitted	NULL
December	NULL
21	NULL
,	NULL
1995	NULL
;	NULL
accepted	NULL
May	NULL
28	NULL
,	NULL
1996	NULL
.	NULL

Supported	NULL
in	NULL
part	NULL
by	NULL
the	NULL
Leukaemia	NULL
Research	NULL
Fund	NULL
and	NULL
the	NULL
Well-come	NULL
Trust	NULL
(	NULL
Grants	NULL
No	NULL
.	NULL

33748	NULL
and	NULL
35981	NULL
)	NULL
.	NULL

Address	NULL
reprint	NULL
requests	NULL
to	NULL
Anthony	NULL
R.	NULL
Green	NULL
,	NULL
PhD	NULL
,	NULL
MRCPath	NULL
,	NULL
FRCP	NULL
,	NULL
University	NULL
of	NULL
Cambridge	NULL
,	NULL
Department	NULL
of	NULL
Haematology	NULL
,	NULL
MRC	NULL
Centre	NULL
,	NULL
Hills	NULL
Rd	NULL
,	NULL
Cambridge	NULL
CB2	NULL
2QH	NULL
,	NULL
UK	NULL
.	NULL

The	NULL
publication	NULL
costs	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
page	NULL
charge	NULL
payment	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
``	NULL
advertisement	NULL
``	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

Â©	NULL
1996	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
.	NULL

0006-497	NULL
1/96/8807-0018	NULL
$	NULL
3.00/0	NULL
2690	NULL
ited	NULL
allele	NULL
loss	NULL
on	NULL
20q	NULL
.	NULL

in	NULL
each	NULL
case	NULL
the	NULL
allele	NULL
loss	NULL
was	NULL
caused	NULL
by	NULL
an	NULL
interstitial	NULL
deletion	NULL
because	NULL
heterozygosity	NULL
at	NULL
distal	NULL
markers	NULL
was	NULL
retained	NULL
and	NULL
because	NULL
quantitative	NULL
Southern	NULL
blotting	NULL
demonstrated	NULL
hemizygosity	NULL
.	NULL

Loss	NULL
of	NULL
heterozygosity	NULL
in	NULL
PB	NULL
granulocytes	NULL
would	NULL
be	NULL
masked	NULL
by	NULL
the	NULL
presence	NULL
of	NULL
significant	NULL
numbers	NULL
of	NULL
normal	NULL
granulocytes	NULL
not	NULL
derived	NULL
from	NULL
the	NULL
malignant	NULL
clone	NULL
.	NULL

Therefore	NULL
,	NULL
the	NULL
human	NULL
androgen	NULL
receptor	NULL
assay	NULL
(	NULL
HUMARA	NULL
)	NULL
was	NULL
used	NULL
to	NULL
determine	NULL
granulocyte	NULL
clonality	NULL
.	NULL

In	NULL
21	NULL
of	NULL
27	NULL
informative	NULL
female	NULL
patients	NULL
the	NULL
majority	NULL
of	NULL
the	NULL
granulocytes	NULL
were	NULL
clonally	NULL
derived	NULL
.	NULL

In	NULL
5	NULL
patients	NULL
the	NULL
granulocytes	NULL
appeared	NULL
polyclonal	NULL
and	NULL
in	NULL
1	NULL
patient	NULL
unilateral	NULL
X	NULL
inactivation	NULL
was	NULL
observed	NULL
in	NULL
both	NULL
granulocytes	NULL
and	NULL
T	NULL
cells	NULL
.	NULL

These	NULL
results	NULL
show	NULL
that	NULL
,	NULL
in	NULL
the	NULL
vast	NULL
majority	NULL
of	NULL
patients	NULL
presented	NULL
here	NULL
,	NULL
the	NULL
failure	NULL
to	NULL
detect	NULL
loss	NULL
of	NULL
heterozygosity	NULL
can	NULL
not	NULL
be	NULL
attributed	NULL
to	NULL
the	NULL
presence	NULL
of	NULL
normal	NULL
polyclonal	NULL
granulocytes	NULL
.	NULL

Our	NULL
results	NULL
therefore	NULL
show	NULL
that	NULL
allele	NULL
loss	NULL
on	NULL
chromosome	NULL
20q	NULL
in	NULL
polycythemia	NULL
vera	NULL
does	NULL
not	NULL
commonly	NULL
involve	NULL
mitotic	NULL
recombination	NULL
or	NULL
chromosome	NULL
loss	NULL
and	NULL
that	NULL
microsatellite	NULL
instability	NULL
is	NULL
a	NULL
rare	NULL
event	NULL
in	NULL
this	NULL
disorder	NULL
.	NULL

Â©	NULL
1996	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
.	NULL

centered	NULL
on	NULL
the	NULL
proximal	NULL
G	NULL
(	NULL
+	NULL
)	NULL
band	NULL
,	NULL
20q12	NULL
.	NULL

Microsatellite	NULL
polymerase	NULL
chain	NULL
reaction	NULL
(	NULL
PCR	NULL
)	NULL
and	NULL
quantitative	NULL
Southern	NULL
blot	NULL
analysis	NULL
were	NULL
subsequently	NULL
used	NULL
to	NULL
characterize	NULL
20q	NULL
deletions	NULL
in	NULL
cell	NULL
lines	NULL
and	NULL
peripheral	NULL
blood	NULL
(	NULL
PB	NULL
)	NULL
granulocytes	NULL
.	NULL

Heterogeneity	NULL
of	NULL
both	NULL
centromeric	NULL
and	NULL
telomeric	NULL
breakpoints	NULL
was	NULL
shown	NULL
,	NULL
thus	NULL
supporting	NULL
the	NULL
existence	NULL
of	NULL
one	NULL
or	NULL
more	NULL
tumor	NULL
suppressor	NULL
genes	NULL
on	NULL
20q	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
we	NULL
defined	NULL
a	NULL
common	NULL
deleted	NULL
region	NULL
of	NULL
16	NULL
to	NULL
21	NULL
cM	NULL
which	NULL
contains	NULL
ADA	NULL
,	NULL
PLCI	NULL
,	NULL
TOPI	NULL
,	NULL
SEMG1	NULL
,	NULL
and	NULL
PPGB	NULL
.	NULL

Several	NULL
candidate	NULL
tumor	NULL
suppressor	NULL
genes	NULL
were	NULL
found	NULL
to	NULL
lie	NULL
outside	NULL
the	NULL
common	NULL
deleted	NULL
region	NULL
,	NULL
including	NULL
SRC	NULL
,	NULL
HCK	NULL
,	NULL
RBL	NULL
]	NULL
(	NULL
p107	NULL
)	NULL
,	NULL
PTPN1	NULL
,	NULL
and	NULL
CEBPB	NULL
.	NULL

Loss	NULL
of	NULL
heterozygosity	NULL
for	NULL
polymorphic	NULL
markers	NULL
is	NULL
frequently	NULL
observed	NULL
in	NULL
a	NULL
wide	NULL
variety	NULL
of	NULL
tumors	NULL
and	NULL
in	NULL
several	NULL
cases	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
mark	NULL
the	NULL
site	NULL
of	NULL
tumor	NULL
suppressor	NULL
genes	NULL
.	NULL
``	NULL

Loss	NULL
of	NULL
heterozygosity	NULL
can	NULL
result	NULL
from	NULL
several	NULL
mechanisms	NULL
including	NULL
mitotic	NULL
recombination	NULL
,	NULL
gene	NULL
conver-sion	NULL
,	NULL
chromosome	NULL
deletion	NULL
,	NULL
and	NULL
chromosome	NULL
nondisjunction	NULL
with	NULL
or	NULL
without	NULL
reduplication	NULL
.	NULL
``	NULL

Different	NULL
mechanisms	NULL
account	NULL
for	NULL
loss	NULL
of	NULL
heterozygosity	NULL
in	NULL
different	NULL
tumors	NULL
:	NULL
loss	NULL
and	NULL
reduplication	NULL
of	NULL
chromosome	NULL
13	NULL
occurs	NULL
commonly	NULL
in	NULL
retinoblastomas	NULL
'	NULL
``	NULL
``	NULL
;	NULL
whole	NULL
chromosome	NULL
loss	NULL
resulting	NULL
in	NULL
mo-nosomy	NULL
for	NULL
chromosome	NULL
10	NULL
occurs	NULL
frequently	NULL
in	NULL
glioblas-toma	NULL
``	NULL
;	NULL
whereas	NULL
mitotic	NULL
recombination	NULL
involving	NULL
chromosomes	NULL
17p	NULL
and	NULL
11	NULL
is	NULL
the	NULL
major	NULL
mechanism	NULL
in	NULL
glioma	NULL
and	NULL
rhabdomyosarcoma	NULL
.	NULL
``	NULL

Mutations	NULL
in	NULL
genes	NULL
responsible	NULL
for	NULL
fidelity	NULL
of	NULL
DNA	NULL
replication	NULL
and/or	NULL
repair	NULL
represent	NULL
a	NULL
recently	NULL
recognized	NULL
class	NULL
of	NULL
genetic	NULL
alterations	NULL
in	NULL
cancer	NULL
.	NULL

The	NULL
resultant	NULL
genomic	NULL
instability	NULL
can	NULL
manifest	NULL
as	NULL
alterations	NULL
in	NULL
the	NULL
length	NULL
of	NULL
simple	NULL
repeat	NULL
sequences	NULL
between	NULL
tumor	NULL
and	NULL
normal	NULL
tissues	NULL
.	NULL
``	NULL

Originally	NULL
described	NULL
in	NULL
hereditary	NULL
nonpolyposis	NULL
colon	NULL
cancer	NULL
and	NULL
sporadic	NULL
colorectal	NULL
cancer	NULL
as	NULL
well	NULL
as	NULL
other	NULL
sporadic	NULL
epithelial	NULL
tumors	NULL
,	NULL
``	NULL
``	NULL
``	NULL
'	NULL
instability	NULL
of	NULL
simple	NULL
repeat	NULL
sequences	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
occur	NULL
at	NULL
variable	NULL
rates	NULL
in	NULL
hematologic	NULL
malignan-	NULL
Blood	NULL
,	NULL
Vol	NULL
88	NULL
,	NULL
No	NULL
7	NULL
(	NULL
October	NULL
1	NULL
)	NULL
,	NULL
1996	NULL
:	NULL
pp	NULL
2690-2698	NULL
MECHANISMS	NULL
FOR	NULL
LOH	NULL
ON	NULL
CHROMOSOME	NULL
20q	NULL
cies	NULL
.	NULL
``	NULL

In	NULL
the	NULL
only	NULL
study	NULL
of	NULL
microsatellite	NULL
instability	NULL
in	NULL
myeloproliferative	NULL
disorders	NULL
,	NULL
a	NULL
high	NULL
incidence	NULL
was	NULL
reported	NULL
in	NULL
the	NULL
accelerated	NULL
and	NULL
blastic	NULL
phase	NULL
but	NULL
not	NULL
the	NULL
chronic	NULL
phase	NULL
of	NULL
chronic	NULL
myeloid	NULL
leukemia	NULL
.	NULL
``	NULL

Relatively	NULL
little	NULL
is	NULL
known	NULL
about	NULL
the	NULL
role	NULL
of	NULL
tumor	NULL
suppressor	NULL
genes	NULL
,	NULL
including	NULL
mutator	NULL
genes	NULL
,	NULL
in	NULL
the	NULL
pathogenesis	NULL
of	NULL
the	NULL
myeloproliferative	NULL
disorders	NULL
.	NULL

Cytogenetically	NULL
visible	NULL
chromosomal	NULL
deletions	NULL
[	NULL
eg	NULL
,	NULL
del	NULL
(	NULL
20q	NULL
)	NULL
,	NULL
del	NULL
(	NULL
13q	NULL
)	NULL
]	NULL
are	NULL
observed	NULL
in	NULL
a	NULL
minority	NULL
of	NULL
cases	NULL
,	NULL
but	NULL
the	NULL
identity	NULL
of	NULL
the	NULL
critical	NULL
target	NULL
genes	NULL
remains	NULL
obscure	NULL
.	NULL

No	NULL
studies	NULL
of	NULL
loss	NULL
of	NULL
heterozygosity	NULL
in	NULL
myeloproliferative	NULL
disorders	NULL
have	NULL
been	NULL
reported	NULL
.	NULL

Neuman	NULL
et	NULL
al	NULL
``	NULL
``	NULL
examined	NULL
60	NULL
patients	NULL
with	NULL
primary	NULL
or	NULL
secondary	NULL
myelodysplastic	NULL
syndrome	NULL
(	NULL
MDS	NULL
)	NULL
for	NULL
loss	NULL
of	NULL
heterozygosity	NULL
on	NULL
chromosomes	NULL
5	NULL
and	NULL
7	NULL
.	NULL

They	NULL
found	NULL
no	NULL
evidence	NULL
for	NULL
loss	NULL
of	NULL
heterozygosity	NULL
other	NULL
than	NULL
by	NULL
major	NULL
deletion	NULL
or	NULL
monosomy	NULL
.	NULL

Similar	NULL
data	NULL
were	NULL
reported	NULL
by	NULL
Shepherd	NULL
et	NULL
al	NULL
``	NULL
``	NULL
in	NULL
a	NULL
study	NULL
investigating	NULL
loss	NULL
of	NULL
heterozygosity	NULL
of	NULL
chromosome	NULL
5	NULL
in	NULL
MDS	NULL
.	NULL

However	NULL
,	NULL
these	NULL
studies	NULL
were	NULL
only	NULL
able	NULL
to	NULL
use	NULL
a	NULL
relatively	NULL
small	NULL
number	NULL
of	NULL
probes	NULL
,	NULL
so	NULL
small	NULL
regions	NULL
of	NULL
loss	NULL
of	NULL
heterozygosity	NULL
may	NULL
well	NULL
have	NULL
been	NULL
missed	NULL
.	NULL

Moreover	NULL
,	NULL
clonality	NULL
studies	NULL
were	NULL
not	NULL
performed	NULL
in	NULL
either	NULL
of	NULL
these	NULL
reports	NULL
.	NULL

Although	NULL
the	NULL
precise	NULL
correlation	NULL
between	NULL
genetic	NULL
and	NULL
physical	NULL
distances	NULL
is	NULL
not	NULL
yet	NULL
clear	NULL
,	NULL
the	NULL
common	NULL
deleted	NULL
region	NULL
clearly	NULL
spans	NULL
a	NULL
large	NULL
segment	NULL
of	NULL
the	NULL
chromosomal	NULL
arm	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
have	NULL
attempted	NULL
to	NULL
narrow	NULL
the	NULL
region	NULL
of	NULL
interest	NULL
by	NULL
searching	NULL
for	NULL
small	NULL
deletions	NULL
or	NULL
mitotic	NULL
recombination	NULL
events	NULL
,	NULL
neither	NULL
of	NULL
which	NULL
would	NULL
be	NULL
detected	NULL
by	NULL
conventional	NULL
cytogenetics	NULL
.	NULL

Patients	NULL
with	NULL
a	NULL
known	NULL
20q	NULL
deletion	NULL
were	NULL
ex-cluded	NULL
.	NULL

A	NULL
high-density	NULL
map	NULL
of	NULL
the	NULL
common	NULL
deleted	NULL
region	NULL
was	NULL
constructed	NULL
and	NULL
a	NULL
panel	NULL
of	NULL
microsatellite	NULL
markers	NULL
mapping	NULL
to	NULL
regular	NULL
intervals	NULL
across	NULL
the	NULL
common	NULL
deleted	NULL
region	NULL
was	NULL
used	NULL
to	NULL
search	NULL
for	NULL
chromosome	NULL
20q	NULL
allelic	NULL
losses	NULL
.	NULL

In	NULL
addition	NULL
we	NULL
used	NULL
the	NULL
HUMARA	NULL
assay	NULL
``	NULL
to	NULL
show	NULL
that	NULL
the	NULL
majority	NULL
of	NULL
PB	NULL
granulocytes	NULL
were	NULL
clonally	NULL
derived	NULL
in	NULL
most	NULL
informative	NULL
patients	NULL
.	NULL

Our	NULL
data	NULL
demonstrate	NULL
that	NULL
microsatellite	NULL
instability	NULL
is	NULL
a	NULL
rare	NULL
event	NULL
and	NULL
that	NULL
the	NULL
main	NULL
mechanism	NULL
underlying	NULL
loss	NULL
of	NULL
heterozygosity	NULL
for	NULL
20q	NULL
sequences	NULL
in	NULL
polycythemia	NULL
vera	NULL
is	NULL
interstitial	NULL
deletion	NULL
rather	NULL
than	NULL
mitotic	NULL
recombination	NULL
or	NULL
chromosome	NULL
loss	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Patients	NULL
.	NULL

PB	NULL
samples	NULL
from	NULL
48	NULL
patients	NULL
with	NULL
polycythemia	NULL
vera	NULL
and	NULL
4	NULL
patients	NULL
with	NULL
primary	NULL
myelofibrosis	NULL
were	NULL
studied	NULL
.	NULL

All	NULL
samples	NULL
were	NULL
obtained	NULL
from	NULL
patients	NULL
attending	NULL
Addenbrookes	NULL
Hospital	NULL
(	NULL
Cam-bridge	NULL
,	NULL
UK	NULL
)	NULL
or	NULL
St	NULL
Thomas	NULL
's	NULL
Hospital	NULL
.	NULL

Diagnosis	NULL
of	NULL
polycythemia	NULL
vera	NULL
was	NULL
established	NULL
according	NULL
to	NULL
the	NULL
Polycythemia	NULL
Vera	NULL
Study	NULL
Group	NULL
(	NULL
PVSG	NULL
)	NULL
criteria	NULL
.	NULL

The	NULL
median	NULL
time	NULL
from	NULL
diagnosis	NULL
of	NULL
polycythemia	NULL
vera	NULL
was	NULL
8	NULL
years	NULL
(	NULL
range	NULL
,	NULL
1	NULL
to	NULL
28	NULL
years	NULL
)	NULL
.	NULL

All	NULL
PV	NULL
patients	NULL
except	NULL
two	NULL
male	NULL
patients	NULL
had	NULL
received	NULL
myelosuppressive	NULL
therapy	NULL
(	NULL
P	NULL
,	NULL
busulfan	NULL
,	NULL
or	NULL
hydroxyurea	NULL
)	NULL
.	NULL

Two	NULL
patients	NULL
with	NULL
idiopathic	NULL
myelofibrosis	NULL
were	NULL
diagnosed	NULL
in	NULL
1993	NULL
,	NULL
1	NULL
patient	NULL
in	NULL
1992	NULL
,	NULL
and	NULL
1	NULL
patient	NULL
in	NULL
1991	NULL
.	NULL

Cell	NULL
separation	NULL
.	NULL

-	NULL
Highly	NULL
purified	NULL
granulocyte	NULL
and	NULL
T-cell	NULL
fractions	NULL
were	NULL
prepared	NULL
from	NULL
PB	NULL
using	NULL
magnetic	NULL
beads	NULL
conjugated	NULL
to	NULL
anti-CD15	NULL
and	NULL
anti-CD2	NULL
antibodies	NULL
,	NULL
respectively	NULL
(	NULL
Dynabeads	NULL
;	NULL
Dynal	NULL
,	NULL
Oslo	NULL
,	NULL
Norway	NULL
)	NULL
.	NULL

Ten	NULL
to	NULL
20	NULL
mL	NULL
of	NULL
EDTA-anticoagulated	NULL
blood	NULL
was	NULL
layered	NULL
onto	NULL
Histopaque	NULL
1077	NULL
cushions	NULL
(	NULL
Sigma	NULL
,	NULL
St	NULL
Louis	NULL
,	NULL
MO	NULL
)	NULL
.	NULL

Cells	NULL
from	NULL
the	NULL
mononuclear	NULL
fraction	NULL
were	NULL
washed	NULL
in	NULL
phosphate-buffered	NULL
saline/0.1	NULL
%	NULL
bovine	NULL
serum	NULL
albumin	NULL
and	NULL
incubated	NULL
with	NULL
anti-CD2	NULL
conjugated	NULL
beads	NULL
according	NULL
to	NULL
manufacturer	NULL
's	NULL
recommendations	NULL
.	NULL

Cells	NULL
from	NULL
the	NULL
granulocyte	NULL
pellet	NULL
were	NULL
similarly	NULL
processed	NULL
with	NULL
anti	NULL
2691	NULL
cM	NULL
e	NULL
413-	NULL
D20S106	NULL
-	NULL
D20Ss174	NULL
5	NULL
-l	NULL
|-	NULL
pzos1t0o7	NULL
|-	NULL
PLC1	NULL
10	NULL
-|-	NULL
p2os108	NULL
CDR	NULL
-	NULL
pzost10	NULL
|	NULL
D20sss	NULL
15	NULL
Â©20s46	NULL
|	NULL
pposi89	NULL
[	NULL
-	NULL
apa	NULL
a	NULL
)	NULL
[	NULL
-	NULL
9208119	NULL
|-	NULL
pzos17	NULL
loans	NULL
â	NULL
25	NULL
i~	NULL
p20s197	NULL
D20S16	NULL
3Â°	NULL
i-	NULL
pz0os176	NULL
35	NULL
40	NULL
as	NULL
|-	NULL
D20Ss60	NULL
|-	NULL
b20s100	NULL
so	NULL
I-	NULL
D2os102	NULL
Fig	NULL
1	NULL
.	NULL

-	NULL
Sex-averaged	NULL
genetic	NULL
map	NULL
of	NULL
the	NULL
common	NULL
deleted	NULL
region	NULL
.	NULL

Loci	NULL
that	NULL
could	NULL
be	NULL
uniquely	NULL
ordered	NULL
are	NULL
shown	NULL
against	NULL
a	NULL
centimorgan	NULL
scale	NULL
.	NULL

The	NULL
most	NULL
likely	NULL
locations	NULL
of	NULL
loci	NULL
that	NULL
could	NULL
not	NULL
be	NULL
uniquely	NULL
placed	NULL
are	NULL
indicated	NULL
by	NULL
vertical	NULL
bars	NULL
on	NULL
the	NULL
right-hand	NULL
side	NULL
.	NULL

The	NULL
proximal	NULL
limit	NULL
of	NULL
the	NULL
common	NULL
deleted	NULL
region	NULL
(	NULL
CDR	NULL
)	NULL
is	NULL
defined	NULL
by	NULL
Asimakopoulos	NULL
et	NULL
al	NULL
``	NULL
``	NULL
and	NULL
the	NULL
distal	NULL
limit	NULL
by	NULL
Roulston	NULL
et	NULL
al	NULL
.	NULL
``	NULL

''	NULL
CD15	NULL
beads	NULL
.	NULL

In	NULL
each	NULL
case	NULL
the	NULL
percentage	NULL
of	NULL
Dynabead-bound	NULL
cells	NULL
was	NULL
determined	NULL
after	NULL
each	NULL
separation	NULL
procedure	NULL
using	NULL
a	NULL
counting	NULL
chamber	NULL
.	NULL

This	NULL
was	NULL
routinely	NULL
in	NULL
the	NULL
range	NULL
of	NULL
90	NULL
%	NULL
to	NULL
100	NULL
%	NULL
.	NULL

Cells	NULL
were	NULL
suspended	NULL
in	NULL
sterile	NULL
,	NULL
autoclaved	NULL
water	NULL
at	NULL
a	NULL
concentration	NULL
of	NULL
10Â°	NULL
cells/mL	NULL
,	NULL
boiled	NULL
for	NULL
5	NULL
minutes	NULL
,	NULL
and	NULL
stored	NULL
at	NULL
-80Â°C	NULL
until	NULL
required	NULL
.	NULL

Microsatellite	NULL
PCR	NULL
.	NULL

Microsatellite	NULL
PCR	NULL
was	NULL
performed	NULL
essentially	NULL
as	NULL
previously	NULL
described	NULL
.	NULL
``	NULL

Briefly	NULL
,	NULL
aliquots	NULL
of	NULL
1,250	NULL
cells	NULL
in	NULL
12.5	NULL
uL	NULL
of	NULL
water	NULL
were	NULL
amplified	NULL
in	NULL
25	NULL
uL	NULL
of	NULL
PCR	NULL
reaction	NULL
mixtures	NULL
containing	NULL
buffer	NULL
(	NULL
50	NULL
mmoV/L	NULL
KCl	NULL
,	NULL
10	NULL
mmol/L	NULL
Tris	NULL
HCl	NULL
pH	NULL
8.3	NULL
,	NULL
1.5	NULL
mmol/L	NULL
MgC	NULL
]	NULL
;	NULL
,	NULL
0.1	NULL
%	NULL
gelatine	NULL
)	NULL
,	NULL
dNTPs	NULL
(	NULL
125	NULL
pmol/L	NULL
each	NULL
)	NULL
,	NULL
primers	NULL
(	NULL
25	NULL
pmol	NULL
each	NULL
)	NULL
,	NULL
and	NULL
Taq	NULL
polymerase	NULL
(	NULL
0.5	NULL
U	NULL
)	NULL
.	NULL

In	NULL
each	NULL
reaction	NULL
mixture	NULL
1/10	NULL
of	NULL
one	NULL
of	NULL
the	NULL
primers	NULL
was	NULL
end-labeled	NULL
with	NULL
``	NULL
P-ATP	NULL
using	NULL
polynucleotide	NULL
kinase	NULL
.	NULL

Samples	NULL
were	NULL
amplified	NULL
in	NULL
an	NULL
MJ	NULL
Research	NULL
programmable	NULL
thermal	NULL
controller	NULL
(	NULL
MJ	NULL
Research	NULL
,	NULL
Watertown	NULL
,	NULL
MA	NULL
)	NULL
for	NULL
30	NULL
cycles	NULL
(	NULL
94Â°C	NULL
for	NULL
40	NULL
seconds	NULL
;	NULL
annealing	NULL
temperature	NULL
for	NULL
30	NULL
seconds	NULL
;	NULL
no	NULL
extension	NULL
step	NULL
)	NULL
with	NULL
an	NULL
initial	NULL
denaturation	NULL
(	NULL
94Â°C	NULL
,	NULL
5	NULL
minutes	NULL
)	NULL
and	NULL
a	NULL
final	NULL
extension	NULL
step	NULL
(	NULL
72Â°C	NULL
,	NULL
15	NULL
minutes	NULL
)	NULL
.	NULL

Samples	NULL
were	NULL
analyzed	NULL
on	NULL
8	NULL
mol/L	NULL
urea	NULL
,	NULL
6	NULL
%	NULL
polyacrylamide	NULL
gels	NULL
followed	NULL
by	NULL
autoradiography	NULL
.	NULL

Primer	NULL
sequences	NULL
are	NULL
available	NULL
from	NULL
the	NULL
Genome	NULL
Data	NULL
Base	NULL
(	NULL
GDB	NULL
;	NULL
Johns	NULL
Hopkins	NULL
University	NULL
,	NULL
Baltimore	NULL
,	NULL
MD	NULL
)	NULL
except	NULL
AFMa132xe9	NULL
(	NULL
communicated	NULL
by	NULL
J.	NULL
Weissenbach	NULL
[	NULL
GÃ©nÃ©thon	NULL
,	NULL
Paris	NULL
,	NULL
France	NULL
]	NULL
on	NULL
a	NULL
collaborative	NULL
basis	NULL
)	NULL
.	NULL

2692	NULL
Table	NULL
1	NULL
.	NULL

Analysis	NULL
of	NULL
Granulocyte	NULL
DNA	NULL
for	NULL
Loss	NULL
of	NULL
Heterozygosity	NULL
Locus	NULL
Two	NULL
Alleles	NULL
One	NULL
Allele	NULL
Uninformative	NULL
D20S107	NULL
34	NULL
3	NULL
15	NULL
PLC1	NULL
41	NULL
4	NULL
7	NULL
D20S108	NULL
32	NULL
3	NULL
17	NULL
D20S110	NULL
36	NULL
2	NULL
13	NULL
D20S46	NULL
44	NULL
2	NULL
6	NULL
D20S55	NULL
44	NULL
4	NULL
4	NULL
D20S169	NULL
39	NULL
1	NULL
11	NULL
D20S119	NULL
32	NULL
2	NULL
18	NULL
AFMa132xe9	NULL
42	NULL
3	NULL
7	NULL
D20S43	NULL
41	NULL
2	NULL
9	NULL
D20S16	NULL
44	NULL
3	NULL
4	NULL
D20S197	NULL
42	NULL
3	NULL
7	NULL
D20S176	NULL
37	NULL
2	NULL
13	NULL
D20S60	NULL
42	NULL
2	NULL
8	NULL
Â©20S100	NULL
44	NULL
1	NULL
7	NULL
D20S102	NULL
37	NULL
0	NULL
15	NULL
PCK1	NULL
40	NULL
0	NULL
12	NULL
Microsatellite	NULL
PCR	NULL
was	NULL
performed	NULL
on	NULL
DNA	NULL
from	NULL
highly	NULL
purified	NULL
granulocytes	NULL
and	NULL
T	NULL
cells	NULL
.	NULL

Primer	NULL
pairs	NULL
corresponding	NULL
to	NULL
17	NULL
loci	NULL
on	NULL
chromosome	NULL
20q	NULL
were	NULL
used	NULL
.	NULL

``	NULL
'Two	NULL
Alleles	NULL
``	NULL
denotes	NULL
the	NULL
presence	NULL
of	NULL
two	NULL
alleles	NULL
in	NULL
granulocyte	NULL
DNA	NULL
at	NULL
an	NULL
informative	NULL
locus	NULL
(	NULL
ie	NULL
,	NULL
one	NULL
for	NULL
which	NULL
two	NULL
alleles	NULL
were	NULL
detected	NULL
in	NULL
T-cell	NULL
DNA	NULL
)	NULL
.	NULL

``	NULL
One	NULL
Allele	NULL
``	NULL
denotes	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
single	NULL
allele	NULL
in	NULL
granulocyte	NULL
DNA	NULL
at	NULL
an	NULL
informative	NULL
locus	NULL
.	NULL

Results	NULL
were	NULL
assessed	NULL
by	NULL
visual	NULL
inspection	NULL
of	NULL
autoradiographs	NULL
.	NULL

We	NULL
have	NULL
previously	NULL
shown	NULL
that	NULL
this	NULL
method	NULL
can	NULL
detect	NULL
allele	NULL
loss	NULL
if	NULL
present	NULL
in	NULL
=40	NULL
%	NULL
of	NULL
cells	NULL
.	NULL
``	NULL

''	NULL
Numbers	NULL
represent	NULL
the	NULL
number	NULL
of	NULL
patients	NULL
for	NULL
which	NULL
each	NULL
marker	NULL
was	NULL
tested	NULL
.	NULL

In	NULL
three	NULL
patients	NULL
with	NULL
interstitial	NULL
deletions	NULL
,	NULL
a	NULL
few	NULL
markers	NULL
predicted	NULL
to	NULL
map	NULL
within	NULL
the	NULL
deletions	NULL
were	NULL
not	NULL
assayed	NULL
(	NULL
see	NULL
Table	NULL
2	NULL
)	NULL
.	NULL

HUMARA	NULL
clonality	NULL
assay	NULL
.	NULL

_	NULL
Aliquots	NULL
of	NULL
10,000	NULL
Dynabead-sepa-rated	NULL
cells	NULL
in	NULL
100	NULL
LL	NULL
of	NULL
water	NULL
were	NULL
phenol	NULL
chloroform	NULL
extracted	NULL
and	NULL
the	NULL
DNA	NULL
precipitated	NULL
using	NULL
glycogen	NULL
as	NULL
carrier	NULL
.	NULL

DNA	NULL
pellets	NULL
were	NULL
resuspended	NULL
in	NULL
14	NULL
L	NULL
of	NULL
1	NULL
%	NULL
Hha	NULL
I	NULL
buffer	NULL
and	NULL
40	NULL
U	NULL
of	NULL
enzyme	NULL
added	NULL
.	NULL

Reactions	NULL
were	NULL
left	NULL
to	NULL
proceed	NULL
at	NULL
37Â°C	NULL
overnight	NULL
.	NULL

Digested	NULL
A	NULL
B	NULL
G	NULL
T	NULL
G	NULL
T	NULL
G	NULL
T	NULL
Â«	NULL
tn	NULL
â	NULL
3	NULL
#	NULL
Z	NULL
D20S119	NULL
D208102	NULL
D20S176	NULL
D20S100	NULL
ASIMAKOPOULOS	NULL
ET	NULL
AL	NULL
Table	NULL
2	NULL
.	NULL

Details	NULL
of	NULL
Allele	NULL
Loss	NULL
in	NULL
Granulocyte	NULL
DNA	NULL
From	NULL
Patients	NULL
With	NULL
Loss	NULL
of	NULL
Heterozygosity	NULL
Patients	NULL
Locus	NULL
HS	NULL
PP	NULL
HH	NULL
IN	NULL
D20S107	NULL
1	NULL
1	NULL
1	NULL
U	NULL
PLC1	NULL
1	NULL
1	NULL
1	NULL
1	NULL
D20S108	NULL
1	NULL
1	NULL
U	NULL
1	NULL
D20S110	NULL
1	NULL
1	NULL
1	NULL
ND	NULL
D20S46	NULL
U	NULL
1	NULL
U	NULL
1	NULL
D20S55	NULL
1	NULL
1	NULL
1	NULL
1	NULL
D20S169	NULL
1	NULL
U	NULL
U	NULL
ND	NULL
D20S119	NULL
1	NULL
U	NULL
1	NULL
U	NULL
AFMa132xe9	NULL
1	NULL
1	NULL
U	NULL
1	NULL
D20S43	NULL
U	NULL
1	NULL
U	NULL
1	NULL
D20S16	NULL
1	NULL
1	NULL
1	NULL
ND	NULL
D20S197	NULL
U	NULL
1	NULL
1	NULL
1	NULL
D20S176	NULL
ND	NULL
1	NULL
U	NULL
1	NULL
D20S60	NULL
2	NULL
1	NULL
2	NULL
1	NULL
Â©20S100	NULL
2	NULL
2	NULL
2	NULL
1	NULL
D20S102	NULL
2	NULL
2	NULL
2	NULL
2	NULL
PCK1	NULL
2	NULL
2	NULL
2	NULL
U	NULL
Microsatellite	NULL
PCR	NULL
was	NULL
performed	NULL
as	NULL
outlined	NULL
in	NULL
the	NULL
legend	NULL
to	NULL
Table	NULL
3	NULL
.	NULL

Abbreviations	NULL
:	NULL
2	NULL
,	NULL
two	NULL
alleles	NULL
were	NULL
amplified	NULL
from	NULL
granulocyte	NULL
DNA	NULL
at	NULL
an	NULL
informative	NULL
locus	NULL
(	NULL
ie	NULL
,	NULL
one	NULL
for	NULL
which	NULL
two	NULL
alleles	NULL
were	NULL
detected	NULL
in	NULL
T	NULL
cell	NULL
DNA	NULL
)	NULL
;	NULL
1	NULL
,	NULL
a	NULL
single	NULL
allele	NULL
was	NULL
amplified	NULL
from	NULL
granulocyte	NULL
DNA	NULL
at	NULL
an	NULL
informative	NULL
locus	NULL
;	NULL
U	NULL
,	NULL
uninformative	NULL
;	NULL
ND	NULL
,	NULL
not	NULL
done	NULL
.	NULL

DNA	NULL
was	NULL
then	NULL
added	NULL
to	NULL
a	NULL
final	NULL
volume	NULL
of	NULL
30	NULL
LL	NULL
of	NULL
PCR	NULL
mixtures	NULL
at	NULL
the	NULL
same	NULL
concentrations	NULL
of	NULL
reagents	NULL
as	NULL
for	NULL
other	NULL
microsatellite	NULL
PCR	NULL
reactions	NULL
(	NULL
see	NULL
above	NULL
)	NULL
.	NULL

Samples	NULL
were	NULL
amplified	NULL
in	NULL
an	NULL
MJ	NULL
Research	NULL
programmable	NULL
thermal	NULL
controller	NULL
for	NULL
30	NULL
cycles	NULL
(	NULL
94Â°C	NULL
for	NULL
40	NULL
seconds	NULL
;	NULL
65Â°C	NULL
for	NULL
30	NULL
seconds	NULL
;	NULL
72Â°C	NULL
for	NULL
30	NULL
seconds	NULL
)	NULL
with	NULL
an	NULL
initial	NULL
denaturation	NULL
(	NULL
94Â°C	NULL
,	NULL
5	NULL
minutes	NULL
)	NULL
and	NULL
a	NULL
final	NULL
extension	NULL
step	NULL
(	NULL
72Â°C	NULL
,	NULL
15	NULL
minutes	NULL
)	NULL
.	NULL

Products	NULL
were	NULL
analyzed	NULL
on	NULL
gels	NULL
prepared	NULL
in	NULL
the	NULL
same	NULL
way	NULL
as	NULL
for	NULL
other	NULL
microsatellite	NULL
PCR	NULL
products	NULL
.	NULL

Band	NULL
densities	NULL
were	NULL
measured	NULL
on	NULL
autoradiographic	NULL
films	NULL
using	NULL
NIH	NULL
Image	NULL
Analysis	NULL
Software	NULL
vs.	NULL
C	NULL
GT	NULL
GT	NULL
GT	NULL
PLC	NULL
.	NULL

!	NULL
``	NULL

``	NULL
25208100	NULL
Fig	NULL
2	NULL
.	NULL

Loss	NULL
of	NULL
heterozygosity	NULL
for	NULL
loci	NULL
on	NULL
chromosome	NULL
20q	NULL
.	NULL

Microsatellite	NULL
PCR	NULL
was	NULL
performed	NULL
on	NULL
PB	NULL
granulocyte	NULL
DNA	NULL
(	NULL
G	NULL
)	NULL
or	NULL
PB	NULL
T-cell	NULL
DNA	NULL
(	NULL
T	NULL
)	NULL
.	NULL

Corresponding	NULL
loci	NULL
appear	NULL
below	NULL
each	NULL
panel	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Patient	NULL
MD	NULL
.	NULL

Microsatellite	NULL
PCR	NULL
using	NULL
granulocyte	NULL
DNA	NULL
showed	NULL
no	NULL
loss	NULL
of	NULL
heterozygosity	NULL
for	NULL
chromosome	NULL
20q	NULL
markers	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Patient	NULL
PP	NULL
.	NULL

Microsatellite	NULL
PCR	NULL
resulted	NULL
in	NULL
amplification	NULL
of	NULL
two	NULL
alleles	NULL
for	NULL
marker	NULL
D20S100	NULL
but	NULL
only	NULL
one	NULL
allele	NULL
for	NULL
marker	NULL
D20S176	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Patient	NULL
IN	NULL
.	NULL

One	NULL
allele	NULL
is	NULL
consistently	NULL
less	NULL
intense	NULL
in	NULL
granulocytes	NULL
with	NULL
both	NULL
markers	NULL
used	NULL
.	NULL

MECHANISMS	NULL
FOR	NULL
LOH	NULL
ON	NULL
CHROMOSOME	NULL
20q	NULL
p4.8	NULL
ADA	NULL
Fig	NULL
3	NULL
.	NULL

-	NULL
Quantitative	NULL
Southern	NULL
analysis	NULL
of	NULL
granulocyte	NULL
DNA	NULL
from	NULL
patients	NULL
exhibiting	NULL
loss	NULL
of	NULL
heterozy-gosity	NULL
.	NULL

Filters	NULL
were	NULL
hybridized	NULL
to	NULL
the	NULL
control	NULL
probe	NULL
p4.8	NULL
and	NULL
subsequently	NULL
to	NULL
two	NULL
probes	NULL
from	NULL
within	NULL
the	NULL
common	NULL
deleted	NULL
region	NULL
(	NULL
ADA	NULL
and	NULL
SEMG1	NULL
)	NULL
.	NULL

'Â°	NULL
OD	NULL
ratios	NULL
were	NULL
calculated	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

Lane	NULL
1	NULL
,	NULL
granulocytes	NULL
from	NULL
a	NULL
normal	NULL
donor	NULL
;	NULL
lane	NULL
2	NULL
,	NULL
cytogenetically	NULL
normal	NULL
lymphoblastoid	NULL
cell	NULL
line	NULL
KS10	NULL
;	NULL
lane	NULL
3	NULL
,	NULL
lymphoblastoid	NULL
cell	NULL
line	NULL
with	NULL
a	NULL
20q	NULL
deletion	NULL
,	NULL
KS7	NULL
;	NULL
lane	NULL
4	NULL
,	NULL
patient	NULL
HS	NULL
;	NULL
lane	NULL
5	NULL
,	NULL
patient	NULL
PP	NULL
;	NULL
lane	NULL
6	NULL
,	NULL
patient	NULL
HH	NULL
;	NULL
lane	NULL
7	NULL
,	NULL
patient	NULL
IN	NULL
.	NULL

1.57	NULL
(	NULL
this	NULL
software	NULL
is	NULL
in	NULL
the	NULL
public	NULL
domain	NULL
and	NULL
available	NULL
through	NULL
the	NULL
Internet	NULL
)	NULL
.	NULL

Estimation	NULL
of	NULL
the	NULL
percentage	NULL
of	NULL
clonal	NULL
granulocytes	NULL
.	NULL

-	NULL
Percentages	NULL
of	NULL
clonal	NULL
granulocytes	NULL
were	NULL
estimated	NULL
using	NULL
granulocyte	NULL
and	NULL
T-cell	NULL
allele	NULL
intensity	NULL
ratios	NULL
.	NULL

Granulocyte	NULL
and	NULL
T-cell	NULL
DNA	NULL
was	NULL
predigested	NULL
with	NULL
Hha	NULL
I	NULL
and	NULL
amplified	NULL
with	NULL
HUMARA	NULL
primers	NULL
as	NULL
described	NULL
above	NULL
.	NULL

Allele	NULL
ratios	NULL
were	NULL
derived	NULL
by	NULL
dividing	NULL
the	NULL
intensity	NULL
of	NULL
one	NULL
allele	NULL
(	NULL
allele	NULL
1	NULL
)	NULL
by	NULL
the	NULL
intensity	NULL
of	NULL
the	NULL
other	NULL
allele	NULL
(	NULL
allele	NULL
2	NULL
)	NULL
.	NULL

In	NULL
each	NULL
case	NULL
,	NULL
allele	NULL
ratios	NULL
were	NULL
corrected	NULL
for	NULL
preferential	NULL
amplification	NULL
of	NULL
alleles	NULL
by	NULL
comparison	NULL
with	NULL
the	NULL
equivalent	NULL
ratios	NULL
obtained	NULL
from	NULL
undigested	NULL
granulocyte	NULL
or	NULL
T-cell	NULL
DNA	NULL
,	NULL
to	NULL
give	NULL
granulocyte	NULL
and	NULL
T-cell	NULL
``	NULL
corrected	NULL
ratios	NULL
,	NULL
``	NULL
'	NULL
respectively	NULL
.	NULL

A	NULL
mixed	NULL
population	NULL
of	NULL
clonal	NULL
and	NULL
polyclonal	NULL
granulocytes	NULL
consists	NULL
of	NULL
a	NULL
proportion	NULL
of	NULL
cells	NULL
which	NULL
are	NULL
clonal	NULL
(	NULL
designated	NULL
G	NULL
)	NULL
and	NULL
a	NULL
proportion	NULL
of	NULL
polyclonal	NULL
cells	NULL
(	NULL
designated	NULL
Gp	NULL
)	NULL
.	NULL

All	NULL
clonal	NULL
granulocytes	NULL
have	NULL
the	NULL
same	NULL
active	NULL
allele	NULL
(	NULL
eg	NULL
,	NULL
allele	NULL
1	NULL
)	NULL
and	NULL
the	NULL
same	NULL
inactive	NULL
allele	NULL
(	NULL
allele	NULL
2	NULL
)	NULL
.	NULL

Only	NULL
a	NULL
proportion	NULL
of	NULL
the	NULL
polyclonal	NULL
granulocytes	NULL
has	NULL
the	NULL
same	NULL
pattern	NULL
(	NULL
allele	NULL
1	NULL
active	NULL
and	NULL
allele	NULL
2	NULL
inactive	NULL
)	NULL
.	NULL

If	NULL
this	NULL
proportion	NULL
is	NULL
designated	NULL
*	NULL
'	NULL
n	NULL
,	NULL
``	NULL
'	NULL
the	NULL
rest	NULL
of	NULL
the	NULL
polyclonal	NULL
granulocytes	NULL
(	NULL
``	NULL
1	NULL
-	NULL
n	NULL
``	NULL
)	NULL
will	NULL
have	NULL
the	NULL
opposite	NULL
pattern	NULL
(	NULL
allele	NULL
1	NULL
inactive	NULL
and	NULL
allele	NULL
2	NULL
active	NULL
)	NULL
.	NULL

The	NULL
value	NULL
of	NULL
'	NULL
n	NULL
'	NULL
is	NULL
a	NULL
measure	NULL
of	NULL
the	NULL
degree	NULL
of	NULL
unequal	NULL
Lyonization	NULL
in	NULL
a	NULL
polyclonal	NULL
population	NULL
of	NULL
cells	NULL
from	NULL
a	NULL
particular	NULL
patient	NULL
.	NULL

In	NULL
a	NULL
mainly	NULL
clonal	NULL
population	NULL
of	NULL
granulocytes	NULL
amplification	NULL
of	NULL
Hha	NULL
|	NULL
predigested	NULL
DNA	NULL
will	NULL
produce	NULL
a	NULL
strong	NULL
and	NULL
a	NULL
weak	NULL
allele	NULL
.	NULL

The	NULL
weak	NULL
allele	NULL
will	NULL
derive	NULL
solely	NULL
from	NULL
those	NULL
polyclonal	NULL
cells	NULL
that	NULL
have	NULL
an	NULL
allele	NULL
activity	NULL
pattern	NULL
opposite	NULL
to	NULL
that	NULL
of	NULL
clonal	NULL
cells	NULL
.	NULL

Its	NULL
intensity	NULL
can	NULL
be	NULL
represented	NULL
by	NULL
[	NULL
(	NULL
1	NULL
-	NULL
n	NULL
)	NULL
Gp	NULL
]	NULL
.	NULL

The	NULL
intensity	NULL
of	NULL
the	NULL
strong	NULL
allele	NULL
will	NULL
be	NULL
derived	NULL
from	NULL
both	NULL
the	NULL
clonal	NULL
cells	NULL
present	NULL
[	NULL
Gc	NULL
]	NULL
together	NULL
with	NULL
a	NULL
contribution	NULL
from	NULL
the	NULL
polyclonal	NULL
cells	NULL
that	NULL
have	NULL
identical	NULL
allele	NULL
activity	NULL
pattern	NULL
[	NULL
nGp	NULL
]	NULL
.	NULL

Therefore	NULL
,	NULL
the	NULL
corrected	NULL
granulocyte	NULL
ratio	NULL
(	NULL
R	NULL
,	NULL
;	NULL
)	NULL
will	NULL
be	NULL
represented	NULL
by	NULL
the	NULL
following	NULL
equation	NULL
:	NULL
R	NULL
;	NULL
=	NULL
(	NULL
1	NULL
-	NULL
n	NULL
)	NULL
Gp/nGp	NULL
+	NULL
Ge	NULL
(	NULL
equation	NULL
1	NULL
)	NULL
.	NULL

The	NULL
value	NULL
of	NULL
Â»	NULL
(	NULL
degree	NULL
of	NULL
unequal	NULL
Lyonization	NULL
in	NULL
a	NULL
polyclonal	NULL
population	NULL
from	NULL
a	NULL
particular	NULL
patient	NULL
)	NULL
can	NULL
be	NULL
estimated	NULL
from	NULL
the	NULL
T-cell	NULL
corrected	NULL
ratio	NULL
.	NULL

This	NULL
calculation	NULL
is	NULL
based	NULL
on	NULL
two	NULL
premises	NULL
:	NULL
O.D	NULL
.	NULL

ratios	NULL
:	NULL
SEMG1	NULL
O.D	NULL
.	NULL

ratios	NULL
:	NULL
2693	NULL
Â¥	NULL
@	NULL
@	NULL
q	NULL
,	NULL
#	NULL
#	NULL
#	NULL
8	NULL
#	NULL
4	NULL
wt	NULL
1.0	NULL
1.0	NULL
04	NULL
04	NULL
0.4	NULL
0.3	NULL
0.3	NULL
1.0	NULL
1.0	NULL
04	NULL
04	NULL
0.5	NULL
04	NULL
04	NULL
Firstly	NULL
,	NULL
that	NULL
T	NULL
cells	NULL
are	NULL
not	NULL
part	NULL
of	NULL
the	NULL
malignant	NULL
clone	NULL
;	NULL
and	NULL
secondly	NULL
,	NULL
that	NULL
the	NULL
degree	NULL
of	NULL
unequal	NULL
Lyonization	NULL
is	NULL
similar	NULL
in	NULL
granulocytes	NULL
and	NULL
T	NULL
cells	NULL
from	NULL
the	NULL
same	NULL
patient	NULL
.	NULL

The	NULL
T-cell	NULL
corrected	NULL
ratio	NULL
(	NULL
Ry	NULL
)	NULL
will	NULL
be	NULL
equal	NULL
to	NULL
:	NULL
Rf	NULL
=	NULL
(	NULL
1	NULL
-	NULL
n	NULL
)	NULL
Tp/nTp	NULL
(	NULL
equation	NULL
2	NULL
)	NULL
,	NULL
where	NULL
n	NULL
is	NULL
the	NULL
proportion	NULL
of	NULL
cells	NULL
that	NULL
has	NULL
inactivated	NULL
allele	NULL
2	NULL
and	NULL
7	NULL
,	NULL
is	NULL
the	NULL
proportion	NULL
of	NULL
polyclonal	NULL
T	NULL
cells	NULL
.	NULL

If	NULL
all	NULL
T	NULL
cells	NULL
are	NULL
polyclonal	NULL
,	NULL
T	NULL
Â»	NULL
=	NULL
1	NULL
,	NULL
and	NULL
so	NULL
n	NULL
can	NULL
be	NULL
calculated	NULL
from	NULL
Ry	NULL
.	NULL

The	NULL
value	NULL
of	NULL
n	NULL
derived	NULL
from	NULL
equation	NULL
2	NULL
can	NULL
now	NULL
be	NULL
substituted	NULL
into	NULL
the	NULL
first	NULL
equation	NULL
.	NULL

If	NULL
equation	NULL
1	NULL
is	NULL
then	NULL
solved	NULL
for	NULL
G	NULL
,	NULL
then	NULL
the	NULL
following	NULL
equation	NULL
can	NULL
be	NULL
derived	NULL
:	NULL
Ge	NULL
=	NULL
Rf	NULL
-	NULL
RG/Rr	NULL
(	NULL
Re	NULL
+	NULL
1	NULL
)	NULL
(	NULL
equation	NULL
3	NULL
)	NULL
.	NULL

This	NULL
equation	NULL
was	NULL
used	NULL
to	NULL
calculate	NULL
the	NULL
proportion	NULL
of	NULL
clonal	NULL
granulocytes	NULL
presented	NULL
in	NULL
Table	NULL
3	NULL
.	NULL

DNA	NULL
extraction	NULL
and	NULL
quantitative	NULL
Southern	NULL
blotting	NULL
analysis	NULL
.	NULL

High-molecular-weight	NULL
DNA	NULL
was	NULL
extracted	NULL
from	NULL
granulocyte	NULL
pellets	NULL
according	NULL
to	NULL
standard	NULL
methods	NULL
,	NULL
digested	NULL
with	NULL
restriction	NULL
enzymes	NULL
,	NULL
electrophoresed	NULL
in	NULL
0.8	NULL
%	NULL
agarose	NULL
gels	NULL
in	NULL
1	NULL
%	NULL
TBE	NULL
,	NULL
and	NULL
blotted	NULL
onto	NULL
Hybond	NULL
N+	NULL
nylon	NULL
membranes	NULL
(	NULL
L.	NULL
Chalfont	NULL
,	NULL
Bucks	NULL
,	NULL
UK	NULL
)	NULL
using	NULL
capillary	NULL
transfer	NULL
.	NULL

The	NULL
DNA	NULL
was	NULL
alkali	NULL
fixed	NULL
on	NULL
the	NULL
membranes	NULL
and	NULL
hybridized	NULL
to	NULL
50	NULL
ng	NULL
of	NULL
P-labeled	NULL
probe	NULL
DNA	NULL
.	NULL

Probes	NULL
consisted	NULL
of	NULL
an	NULL
ADA	NULL
1.2-kb	NULL
genomic	NULL
fragment	NULL
containing	NULL
exon	NULL
4	NULL
and	NULL
pHSg-6X	NULL
clone	NULL
(	NULL
SEMG1	NULL
)	NULL
.	NULL
'	NULL

''	NULL
A	NULL
probe	NULL
from	NULL
the	NULL
short	NULL
arm	NULL
of	NULL
chromosome	NULL
20	NULL
(	NULL
p4.8	NULL
)	NULL
was	NULL
used	NULL
for	NULL
control	NULL
hybridizations	NULL
.	NULL
``	NULL

Membranes	NULL
were	NULL
washed	NULL
at	NULL
high	NULL
stringency	NULL
(	NULL
0.2	NULL
%	NULL
SSC	NULL
,	NULL
0.1	NULL
%	NULL
sodium	NULL
dodecyl	NULL
sulfate	NULL
,	NULL
2	NULL
X	NULL
15	NULL
minutes	NULL
at	NULL
room	NULL
temperature	NULL
,	NULL
1	NULL
x	NULL
15	NULL
minutes	NULL
at	NULL
65	NULL
to	NULL
68Â°C	NULL
)	NULL
and	NULL
exposed	NULL
to	NULL
autoradiographic	NULL
film	NULL
.	NULL

Band	NULL
intensities	NULL
on	NULL
the	NULL
film	NULL
were	NULL
measured	NULL
using	NULL
the	NULL
NIH	NULL
Image	NULL
Analysis	NULL
software	NULL
vs.1.57	NULL
.	NULL

The	NULL
optical	NULL
density	NULL
ratio	NULL
for	NULL
each	NULL
marker	NULL
was	NULL
calculated	NULL
by	NULL
dividing	NULL
the	NULL
relevant	NULL
band	NULL
density	NULL
with	NULL
the	NULL
band	NULL
density	NULL
for	NULL
the	NULL
control	NULL
probe	NULL
(	NULL
p4.8	NULL
)	NULL
on	NULL
the	NULL
same	NULL
filter	NULL
.	NULL

The	NULL
resultant	NULL
values	NULL
were	NULL
then	NULL
normalized	NULL
by	NULL
comparison	NULL
to	NULL
the	NULL
optical	NULL
density	NULL
(	NULL
OD	NULL
)	NULL
ratio	NULL
obtained	NULL
after	NULL
hybridization	NULL
of	NULL
the	NULL
same	NULL
probes	NULL
to	NULL
DNA	NULL
from	NULL
the	NULL
cytogenetically	NULL
normal	NULL
KS10	NULL
cell	NULL
line	NULL
.	NULL

RESULTS	NULL
Construction	NULL
of	NULL
a	NULL
genetic	NULL
map	NULL
of	NULL
the	NULL
common	NULL
deleted	NULL
region	NULL
.	NULL

A	NULL
number	NULL
of	NULL
genetic	NULL
maps	NULL
of	NULL
the	NULL
human	NULL
genome	NULL
2694	NULL
%	NULL
Hhal	NULL
digested	NULL
DNA	NULL
100	NULL
90	NULL
80	NULL
70	NULL
60	NULL
50	NULL
40	NULL
30	NULL
20	NULL
10	NULL
ASIMAKOPOULOS	NULL
ET	NULL
AL	NULL
0	NULL
N	NULL
seus	NULL
un	NULL
n	NULL
an	NULL
an	NULL
an	NULL
an	NULL
an	NULL
dn	NULL
20	NULL
40	NULL
%	NULL
Hhal	NULL
digested	NULL
DNA	NULL
have	NULL
been	NULL
published	NULL
recently	NULL
.	NULL
``	NULL

However	NULL
,	NULL
the	NULL
GÃ©nÃ©thon	NULL
map	NULL
``	NULL
``	NULL
consisted	NULL
only	NULL
of	NULL
microsatellite	NULL
markers	NULL
isolated	NULL
at	NULL
GÃ©nÃ©thon	NULL
and	NULL
other	NULL
maps	NULL
did	NULL
not	NULL
provide	NULL
good	NULL
coverage	NULL
across	NULL
the	NULL
entire	NULL
common	NULL
deleted	NULL
region	NULL
on	NULL
chromosome	NULL
20q	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
constructed	NULL
a	NULL
high-density	NULL
genetic	NULL
map	NULL
of	NULL
this	NULL
region	NULL
to	NULL
aid	NULL
analysis	NULL
of	NULL
deletions	NULL
and	NULL
loss	NULL
of	NULL
heterozygosity	NULL
in	NULL
this	NULL
locality	NULL
(	NULL
Fig	NULL
1	NULL
)	NULL
.	NULL

The	NULL
map	NULL
was	NULL
constructed	NULL
using	NULL
genotypic	NULL
data	NULL
from	NULL
the	NULL
Cooperative	NULL
Human	NULL
Linkage	NULL
Center	NULL
as	NULL
described	NULL
by	NULL
Aldred	NULL
et	NULL
al	NULL
(	NULL
submitted	NULL
)	NULL
.	NULL

All	NULL
pairs	NULL
of	NULL
loci	NULL
are	NULL
supported	NULL
by	NULL
odds	NULL
of	NULL
at	NULL
least	NULL
250:1	NULL
,	NULL
with	NULL
the	NULL
exception	NULL
of	NULL
D20SÂ§17-D208119	NULL
where	NULL
the	NULL
odds	NULL
against	NULL
inversion	NULL
are	NULL
only	NULL
20:1	NULL
.	NULL

There	NULL
are	NULL
no	NULL
inconsistencies	NULL
between	NULL
this	NULL
and	NULL
other	NULL
published	NULL
genetic	NULL
maps	NULL
.	NULL

``	NULL
``	NULL
*	NULL
``	NULL
The	NULL
data	NULL
are	NULL
also	NULL
in	NULL
agreement	NULL
with	NULL
om	NULL
1.0	NULL
}	NULL
}	NULL
f-	NULL
f	NULL
a	NULL
*y	NULL
|	NULL
o	NULL
m	NULL
-o	NULL
in	NULL
a	NULL
}	NULL
*y	NULL
5	NULL
0-8	NULL
â	NULL
&	NULL
.	NULL

â	NULL
C	NULL
-L	NULL
E	NULL
}	NULL
=	NULL
f	NULL
N	NULL
|	NULL
C	NULL
|	NULL
|	NULL
*~	NULL
3	NULL
C.	NULL
c	NULL
0.6	NULL
FXC	NULL
c	NULL
a	NULL
hou	NULL
\\	NULL
<	NULL
3	NULL
0.4	NULL
k	NULL
____________	NULL
Fig	NULL
4	NULL
.	NULL

HUMARA	NULL
PCR	NULL
conditions	NULL
result	NULL
in	NULL
linear	NULL
'	NULL
3	NULL
*	NULL
A	NULL
amplification	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Autoradiograph	NULL
of	NULL
a	NULL
mixing	NULL
experi-had	NULL
N	NULL
ment	NULL
.	NULL

DNA	NULL
from	NULL
a	NULL
lymphoblastoid	NULL
cell	NULL
line	NULL
derived	NULL
o	NULL
|	NULL
\\	NULL
|	NULL
from	NULL
a	NULL
heterozygous	NULL
female	NULL
patient	NULL
was	NULL
mixed	NULL
at	NULL
'	NULL
C	NULL
0.2	NULL
RT	NULL
stepwise	NULL
increments	NULL
of	NULL
10	NULL
%	NULL
(	NULL
range	NULL
0	NULL
%	NULL
to	NULL
100	NULL
%	NULL
)	NULL
with	NULL
Fra	NULL
*	NULL
``	NULL
I	NULL
%	NULL
Hha	NULL
I-digested	NULL
DNA	NULL
from	NULL
the	NULL
same	NULL
cell	NULL
line	NULL
.	NULL

The	NULL
9	NULL
|	NULL
\	NULL
'	NULL
resulting	NULL
mixes	NULL
were	NULL
amplified	NULL
as	NULL
described	NULL
in	NULL
Mate-	NULL
``	NULL
J	NULL
|	NULL
~	NULL
rials	NULL
and	NULL
Methods	NULL
using	NULL
HUMARA	NULL
primers	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Allele	NULL
-I	NULL
0	NULL
|	NULL
\	NULL
]	NULL
ratios	NULL
(	NULL
fainter	NULL
allele/denser	NULL
allele	NULL
)	NULL
were	NULL
normalized	NULL
<	NULL
Core	NULL
i	NULL
by	NULL
comparison	NULL
to	NULL
the	NULL
ratio	NULL
obtained	NULL
using	NULL
DNA	NULL
not	NULL
predigested	NULL
with	NULL
Hha	NULL
I	NULL
.	NULL

The	NULL
resultant	NULL
values	NULL
were	NULL
plotted	NULL
against	NULL
percentage	NULL
of	NULL
Hha	NULL
I-digested	NULL
DNA	NULL
.	NULL

The	NULL
values	NULL
represent	NULL
the	NULL
mean	NULL
of	NULL
four	NULL
independent	NULL
experiments	NULL
.	NULL

Standard	NULL
deviations	NULL
were	NULL
less	NULL
than	NULL
0.04	NULL
in	NULL
all	NULL
instances	NULL
.	NULL

ordering	NULL
information	NULL
derived	NULL
from	NULL
previous	NULL
analysis	NULL
of	NULL
patients	NULL
with	NULL
20q	NULL
deletions	NULL
and	NULL
with	NULL
a	NULL
physical	NULL
map	NULL
constructed	NULL
across	NULL
the	NULL
common	NULL
deleted	NULL
region	NULL
(	NULL
Aldred	NULL
et	NULL
al	NULL
,	NULL
submitted	NULL
)	NULL
.	NULL

Markers	NULL
AFMa132xe9	NULL
and	NULL
PCK	NULL
]	NULL
were	NULL
not	NULL
present	NULL
in	NULL
the	NULL
genotype	NULL
dataset	NULL
used	NULL
and	NULL
therefore	NULL
could	NULL
not	NULL
be	NULL
mapped	NULL
.	NULL

However	NULL
,	NULL
AFMa132xe9	NULL
maps	NULL
close	NULL
to	NULL
D20S17	NULL
by	NULL
physical	NULL
means	NULL
(	NULL
Aldred	NULL
et	NULL
al	NULL
,	NULL
submitted	NULL
)	NULL
and	NULL
PCK	NULL
]	NULL
has	NULL
been	NULL
reported	NULL
to	NULL
map	NULL
telomeric	NULL
to	NULL
D208	NULL
102	NULL
on	NULL
20q13.2	NULL
(	NULL
First	NULL
International	NULL
Workshop	NULL
on	NULL
Human	NULL
Chromosome	NULL
20	NULL
Mapping	NULL
)	NULL
.	NULL

Loss	NULL
of	NULL
heterozygosity	NULL
on	NULL
chromosome	NULL
204	NULL
in	NULL
PB	NULL
granulocytes	NULL
.	NULL

-	NULL
We	NULL
have	NULL
searched	NULL
for	NULL
loss	NULL
of	NULL
heterozygosity	NULL
on	NULL
chromosome	NULL
20q	NULL
in	NULL
48	NULL
patients	NULL
with	NULL
polycythemia	NULL
vera	NULL
and	NULL
4	NULL
patients	NULL
with	NULL
idiopathic	NULL
myelofibrosis	NULL
.	NULL

Thirteen	NULL
markers	NULL
were	NULL
selected	NULL
that	NULL
span	NULL
the	NULL
common	NULL
deleted	NULL
region	NULL
at	NULL
inter	NULL
MECHANISMS	NULL
FOR	NULL
LOH	NULL
ON	NULL
CHROMOSOME	NULL
20q	NULL
Table	NULL
3	NULL
.	NULL

Densitometric	NULL
Analysis	NULL
of	NULL
HUMARA	NULL
Assay	NULL
Results	NULL
Granulocyte	NULL
T-Cell	NULL
%	NULL
Clonal	NULL
Clonality	NULL
Corrected	NULL
Corrected	NULL
Granulocytes	NULL
Designation	NULL
Patient	NULL
Ratio	NULL
(	NULL
Re	NULL
)	NULL
Ratio	NULL
(	NULL
R4	NULL
)	NULL
(	NULL
Ge	NULL
)	NULL
Clonal	NULL
MM	NULL
0.000	NULL
0.517	NULL
100	NULL
KG	NULL
0.006	NULL
1.007	NULL
99	NULL
vG	NULL
0.015	NULL
3.087	NULL
98	NULL
EG	NULL
0.014	NULL
1.386	NULL
98	NULL
EP	NULL
0.020	NULL
2.040	NULL
97	NULL
JK	NULL
0.015	NULL
0.859	NULL
97	NULL
IG	NULL
0.023	NULL
0.993	NULL
96	NULL
MD	NULL
0.048	NULL
2.073	NULL
93	NULL
|	NULL
DR	NULL
0.016	NULL
0.239	NULL
92	NULL
AB	NULL
0.052	NULL
0.945	NULL
90	NULL
JM	NULL
0.030	NULL
0.311	NULL
88	NULL
DH	NULL
0.123	NULL
1.079	NULL
79	NULL
GP	NULL
0.253	NULL
4.493	NULL
75	NULL
WG	NULL
0.068	NULL
0.274	NULL
71	NULL
aG	NULL
0.169	NULL
0.960	NULL
70	NULL
SB	NULL
0.081	NULL
0.326	NULL
70	NULL
BW	NULL
0.270	NULL
1.855	NULL
67	NULL
Polyclonal	NULL
JM	NULL
0.923	NULL
1.223	NULL
13	NULL
MT	NULL
0.260	NULL
0.524	NULL
40	NULL
MG	NULL
0.462	NULL
0.420	NULL
A	NULL
ES	NULL
0.506	NULL
0.371	NULL
A	NULL
Granulocyte	NULL
and	NULL
T-cell	NULL
clonality	NULL
was	NULL
assessed	NULL
using	NULL
the	NULL
HUMARA	NULL
assay	NULL
.	NULL

All	NULL
experiments	NULL
were	NULL
performed	NULL
on	NULL
at	NULL
least	NULL
two	NULL
occasions	NULL
.	NULL

Densitometric	NULL
analyses	NULL
of	NULL
one	NULL
set	NULL
of	NULL
results	NULL
are	NULL
presented	NULL
here	NULL
.	NULL

Where	NULL
duplicate	NULL
densitometric	NULL
analysis	NULL
was	NULL
possible	NULL
,	NULL
individual	NULL
results	NULL
lay	NULL
within	NULL
10	NULL
%	NULL
of	NULL
the	NULL
mean	NULL
.	NULL

Percentages	NULL
of	NULL
clonal	NULL
granulocytes	NULL
were	NULL
estimated	NULL
using	NULL
the	NULL
formula	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

Allele	NULL
intensity	NULL
ratios	NULL
obtained	NULL
using	NULL
Hha	NULL
I-digested	NULL
DNA	NULL
were	NULL
corrected	NULL
by	NULL
comparison	NULL
with	NULL
the	NULL
equivalent	NULL
ratio	NULL
using	NULL
undigested	NULL
DNA	NULL
.	NULL

Clonality	NULL
designations	NULL
were	NULL
as	NULL
follows	NULL
:	NULL
``	NULL
Clonal	NULL
,	NULL
``	NULL
the	NULL
proportion	NULL
of	NULL
clonal	NULL
granulocytes	NULL
exceeds	NULL
50	NULL
%	NULL
;	NULL
``	NULL
Polyclonal	NULL
,	NULL
``	NULL
the	NULL
proportion	NULL
of	NULL
clonal	NULL
granulocytes	NULL
is	NULL
less	NULL
than	NULL
50	NULL
%	NULL
but	NULL
the	NULL
T-cell	NULL
corrected	NULL
ratio	NULL
is	NULL
greater	NULL
than	NULL
1:3	NULL
;	NULL
``	NULL
Skewed	NULL
,	NULL
``	NULL
the	NULL
proportion	NULL
of	NULL
clonal	NULL
granulocytes	NULL
is	NULL
<	NULL
50	NULL
%	NULL
and	NULL
the	NULL
T-cell	NULL
corrected	NULL
ratio	NULL
is	NULL
<	NULL
1:3	NULL
.	NULL

None	NULL
of	NULL
the	NULL
cases	NULL
amenable	NULL
to	NULL
densitometry	NULL
produced	NULL
a	NULL
``	NULL
skewed	NULL
``	NULL
pattern	NULL
.	NULL

Abbreviations	NULL
:	NULL
R4	NULL
,	NULL
granulocyte	NULL
corrected	NULL
ratio	NULL
;	NULL
R	NULL
;	NULL
,	NULL
T-cell	NULL
corrected	NULL
ratio	NULL
;	NULL
Ge	NULL
,	NULL
percentage	NULL
of	NULL
clonal	NULL
granulocytes	NULL
.	NULL

A	NULL
,	NULL
a	NULL
calculation	NULL
of	NULL
the	NULL
percentage	NULL
of	NULL
clonal	NULL
cells	NULL
gave	NULL
values	NULL
of	NULL
<	NULL
0	NULL
in	NULL
patients	NULL
MG	NULL
and	NULL
ES	NULL
.	NULL

vals	NULL
of	NULL
1	NULL
to	NULL
3	NULL
cM	NULL
.	NULL

The	NULL
unpublished	NULL
GÃ©nÃ©thon	NULL
microsatellite	NULL
AFMa132xe9	NULL
has	NULL
been	NULL
included	NULL
to	NULL
provide	NULL
a	NULL
marker	NULL
between	NULL
D20S119	NULL
and	NULL
D20S17	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
we	NULL
included	NULL
four	NULL
loci	NULL
(	NULL
D20860	NULL
,	NULL
D20S100	NULL
,	NULL
D20S102	NULL
,	NULL
PCK	NULL
]	NULL
)	NULL
that	NULL
map	NULL
to	NULL
20q13.2	NULL
in	NULL
the	NULL
vicinity	NULL
of	NULL
a	NULL
unique	NULL
deletion	NULL
in	NULL
a	NULL
case	NULL
of	NULL
AML	NULL
M4Eo	NULL
reported	NULL
by	NULL
Roulston	NULL
et	NULL
al	NULL
.	NULL
``	NULL

Our	NULL
results	NULL
are	NULL
summarized	NULL
in	NULL
Table	NULL
1	NULL
and	NULL
Fig	NULL
2	NULL
.	NULL

The	NULL
vast	NULL
majority	NULL
of	NULL
patients	NULL
did	NULL
not	NULL
display	NULL
loss	NULL
of	NULL
heterozygosity	NULL
for	NULL
any	NULL
of	NULL
the	NULL
20q	NULL
markers	NULL
used	NULL
(	NULL
Fig	NULL
2A	NULL
)	NULL
.	NULL

However	NULL
,	NULL
allele	NULL
loss	NULL
over	NULL
large	NULL
regions	NULL
of	NULL
chromosome	NULL
20q	NULL
was	NULL
found	NULL
in	NULL
4	NULL
patients	NULL
,	NULL
all	NULL
with	NULL
polycythemia	NULL
vera	NULL
.	NULL

Complete	NULL
or	NULL
near	NULL
complete	NULL
loss	NULL
of	NULL
one	NULL
allele	NULL
was	NULL
seen	NULL
in	NULL
3	NULL
patients	NULL
(	NULL
Fig	NULL
2B	NULL
)	NULL
whereas	NULL
in	NULL
1	NULL
patient	NULL
the	NULL
intensity	NULL
of	NULL
one	NULL
allele	NULL
was	NULL
consistently	NULL
reduced	NULL
(	NULL
Fig	NULL
2C	NULL
)	NULL
.	NULL

The	NULL
results	NULL
in	NULL
the	NULL
latter	NULL
patient	NULL
suggest	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
minor	NULL
subpopulation	NULL
of	NULL
granulocytes	NULL
with	NULL
no	NULL
loss	NULL
of	NULL
heterozygosity	NULL
on	NULL
20q	NULL
.	NULL

In	NULL
each	NULL
of	NULL
the	NULL
4	NULL
patients	NULL
,	NULL
the	NULL
region	NULL
involved	NULL
was	NULL
extensive	NULL
(	NULL
Table	NULL
2	NULL
)	NULL
.	NULL

The	NULL
distal	NULL
breakpoint	NULL
was	NULL
determined	NULL
in	NULL
all	NULL
4	NULL
patients	NULL
.	NULL

Precise	NULL
centromeric	NULL
breakpoints	NULL
were	NULL
not	NULL
defined	NULL
2695	NULL
but	NULL
were	NULL
proximal	NULL
to	NULL
PLC	NULL
]	NULL
in	NULL
all	NULL
4	NULL
cases	NULL
.	NULL

Retention	NULL
of	NULL
heterozygosity	NULL
for	NULL
at	NULL
least	NULL
one	NULL
distal	NULL
marker	NULL
in	NULL
each	NULL
patient	NULL
showed	NULL
that	NULL
the	NULL
mechanism	NULL
responsible	NULL
for	NULL
loss	NULL
of	NULL
heterozygosity	NULL
in	NULL
all	NULL
4	NULL
patients	NULL
did	NULL
not	NULL
involve	NULL
whole	NULL
chromosome	NULL
loss	NULL
or	NULL
simple	NULL
mitotic	NULL
recombination	NULL
.	NULL

Our	NULL
data	NULL
also	NULL
provide	NULL
insight	NULL
into	NULL
the	NULL
prevalence	NULL
of	NULL
microsatellite	NULL
instability	NULL
in	NULL
polycythemia	NULL
vera	NULL
.	NULL

Seventeen	NULL
loci	NULL
were	NULL
examined	NULL
in	NULL
both	NULL
granulocyte	NULL
and	NULL
T-cell	NULL
samples	NULL
from	NULL
52	NULL
patients	NULL
(	NULL
including	NULL
the	NULL
4	NULL
patients	NULL
with	NULL
primary	NULL
myelofi-brosis	NULL
)	NULL
with	NULL
the	NULL
exceptions	NULL
shown	NULL
in	NULL
Table	NULL
2	NULL
.	NULL

Thus	NULL
,	NULL
a	NULL
total	NULL
of	NULL
880	NULL
separate	NULL
comparisons	NULL
between	NULL
granulocyte	NULL
and	NULL
T-cell	NULL
DNA	NULL
were	NULL
performed	NULL
.	NULL

No	NULL
instance	NULL
of	NULL
microsatellite	NULL
instability	NULL
was	NULL
observed	NULL
,	NULL
thus	NULL
demonstrating	NULL
the	NULL
rarity	NULL
of	NULL
the	NULL
process	NULL
in	NULL
polycythemia	NULL
vera	NULL
.	NULL

Loss	NULL
of	NULL
heterozygosity	NULL
resulted	NULL
from	NULL
simple	NULL
interstitial	NULL
deletion	NULL
.	NULL

-	NULL
The	NULL
results	NULL
obtained	NULL
in	NULL
the	NULL
4	NULL
patients	NULL
who	NULL
exhibited	NULL
loss	NULL
of	NULL
heterozygosity	NULL
were	NULL
consistent	NULL
with	NULL
either	NULL
interstitial	NULL
deletion	NULL
or	NULL
complex	NULL
mitotic	NULL
recombination	NULL
events	NULL
.	NULL

Therefore	NULL
,	NULL
quantitative	NULL
Southern	NULL
blotting	NULL
was	NULL
used	NULL
to	NULL
distinguish	NULL
between	NULL
these	NULL
possibilities	NULL
.	NULL

The	NULL
results	NULL
of	NULL
these	NULL
experiments	NULL
appear	NULL
in	NULL
Fig	NULL
3	NULL
.	NULL

In	NULL
all	NULL
four	NULL
patients	NULL
the	NULL
OD	NULL
ratios	NULL
obtained	NULL
using	NULL
two	NULL
probes	NULL
(	NULL
ADA	NULL
and	NULL
SEMG1	NULL
)	NULL
from	NULL
the	NULL
region	NULL
of	NULL
allele	NULL
loss	NULL
'	NULL
``	NULL
were	NULL
approximately	NULL
half	NULL
that	NULL
of	NULL
the	NULL
normal	NULL
controls	NULL
.	NULL

The	NULL
same	NULL
results	NULL
were	NULL
obtained	NULL
for	NULL
both	NULL
probes	NULL
in	NULL
a	NULL
second	NULL
independent	NULL
experiment	NULL
.	NULL

These	NULL
data	NULL
show	NULL
that	NULL
granulocyte	NULL
DNA	NULL
from	NULL
all	NULL
4	NULL
patients	NULL
was	NULL
hemizygous	NULL
for	NULL
ADA	NULL
and	NULL
SEMG1	NULL
,	NULL
a	NULL
finding	NULL
that	NULL
indicates	NULL
the	NULL
presence	NULL
of	NULL
an	NULL
interstitial	NULL
deletion	NULL
and	NULL
not	NULL
mitotic	NULL
recombination	NULL
.	NULL

Analysis	NULL
of	NULL
clonality	NULL
using	NULL
the	NULL
HUMARA	NULL
assay	NULL
.	NULL

-	NULL
Loss	NULL
of	NULL
heterozygosity	NULL
in	NULL
PB	NULL
granulocytes	NULL
would	NULL
be	NULL
masked	NULL
by	NULL
the	NULL
presence	NULL
of	NULL
significant	NULL
numbers	NULL
of	NULL
normal	NULL
granulocytes	NULL
not	NULL
derived	NULL
from	NULL
the	NULL
malignant	NULL
clone	NULL
.	NULL

Moreover	NULL
,	NULL
a	NULL
minority	NULL
of	NULL
patients	NULL
with	NULL
myeloproliferative	NULL
disorders	NULL
have	NULL
been	NULL
reported	NULL
to	NULL
have	NULL
polyclonal	NULL
granulocytes	NULL
.	NULL
``	NULL

To	NULL
ascertain	NULL
to	NULL
what	NULL
extent	NULL
this	NULL
phenomenon	NULL
may	NULL
have	NULL
impaired	NULL
our	NULL
ability	NULL
to	NULL
detect	NULL
loss	NULL
of	NULL
heterozygosity	NULL
,	NULL
we	NULL
assessed	NULL
the	NULL
clonality	NULL
of	NULL
granulocytes	NULL
from	NULL
our	NULL
female	NULL
patients	NULL
.	NULL

It	NULL
was	NULL
decided	NULL
to	NULL
use	NULL
the	NULL
HUMARA	NULL
assay	NULL
because	NULL
of	NULL
its	NULL
high	NULL
rate	NULL
of	NULL
heterozygosity	NULL
and	NULL
consistent	NULL
patterns	NULL
of	NULL
methylation	NULL
.	NULL

``	NULL
*	NULL
``	NULL
``	NULL
We	NULL
developed	NULL
a	NULL
method	NULL
for	NULL
calculating	NULL
the	NULL
percentage	NULL
of	NULL
clonal	NULL
cells	NULL
present	NULL
in	NULL
a	NULL
population	NULL
of	NULL
granulocytes	NULL
(	NULL
see	NULL
Materials	NULL
and	NULL
Methods	NULL
)	NULL
.	NULL

The	NULL
percentage	NULL
of	NULL
clonal	NULL
granulocytes	NULL
is	NULL
calculated	NULL
from	NULL
the	NULL
granulocyte	NULL
corrected	NULL
ratio	NULL
by	NULL
using	NULL
the	NULL
T-cell	NULL
corrected	NULL
ratio	NULL
to	NULL
indicate	NULL
the	NULL
degree	NULL
of	NULL
unequal	NULL
Lyonization	NULL
in	NULL
that	NULL
patient	NULL
.	NULL

To	NULL
use	NULL
the	NULL
allelic	NULL
ratios	NULL
to	NULL
estimate	NULL
the	NULL
proportion	NULL
of	NULL
clonal	NULL
cells	NULL
,	NULL
it	NULL
was	NULL
essential	NULL
to	NULL
prove	NULL
that	NULL
the	NULL
conditions	NULL
used	NULL
for	NULL
HUMARA	NULL
PCR	NULL
resulted	NULL
in	NULL
amplification	NULL
within	NULL
the	NULL
linear	NULL
range	NULL
.	NULL

To	NULL
test	NULL
the	NULL
linearity	NULL
of	NULL
the	NULL
PCR	NULL
conditions	NULL
,	NULL
DNA	NULL
from	NULL
a	NULL
cell	NULL
line	NULL
derived	NULL
from	NULL
a	NULL
heterozygous	NULL
female	NULL
was	NULL
digested	NULL
with	NULL
Rsa	NULL
I	NULL
,	NULL
which	NULL
leaves	NULL
the	NULL
region	NULL
between	NULL
HUMARA	NULL
primers	NULL
intact	NULL
.	NULL

PCR	NULL
using	NULL
Rsa	NULL
I1-digested	NULL
DNA	NULL
should	NULL
result	NULL
in	NULL
amplification	NULL
of	NULL
both	NULL
alleles	NULL
.	NULL

A	NULL
second	NULL
aliquot	NULL
was	NULL
digested	NULL
with	NULL
Rsa	NULL
I	NULL
and	NULL
Hha	NULL
I	NULL
,	NULL
and	NULL
resulted	NULL
in	NULL
amplification	NULL
of	NULL
only	NULL
one	NULL
allele	NULL
.	NULL

DNA	NULL
from	NULL
the	NULL
Rsa	NULL
I-digested	NULL
sample	NULL
was	NULL
mixed	NULL
at	NULL
10	NULL
%	NULL
increments	NULL
with	NULL
DNA	NULL
from	NULL
the	NULL
Rsa	NULL
UHha	NULL
I-digested	NULL
aliquot	NULL
(	NULL
Fig	NULL
4A	NULL
)	NULL
.	NULL

Fifty-four	NULL
nanograms	NULL
of	NULL
resultant	NULL
mixes	NULL
(	NULL
corresponding	NULL
to	NULL
the	NULL
amount	NULL
of	NULL
DNA	NULL
from	NULL
10,000	NULL
diploid	NULL
cells	NULL
``	NULL
)	NULL
was	NULL
amplified	NULL
using	NULL
the	NULL
conditions	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

2696	NULL
ASIMAKOPOULOS	NULL
ET	NULL
AL	NULL
Â«	NULL
#	NULL
Â«	NULL
~	NULL
Fig	NULL
5	NULL
.	NULL

HUMARA	NULL
analysis	NULL
of	NULL
patient	NULL
samples	NULL
.	NULL

DNA	NULL
was	NULL
extracted	NULL
from	NULL
highly	NULL
purified	NULL
PB	NULL
granulocytes	NULL
and	NULL
T	NULL
cells	NULL
and	NULL
amplified	NULL
using	NULL
HUMARA	NULL
primers	NULL
with	NULL
(	NULL
+	NULL
)	NULL
or	NULL
without	NULL
(	NULL
-	NULL
)	NULL
predigestion	NULL
with	NULL
the	NULL
methylation	NULL
sensitive	NULL
enzyme	NULL
HMha	NULL
I	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Patient	NULL
MD	NULL
.	NULL

Monoclonality	NULL
of	NULL
granulocytes	NULL
but	NULL
not	NULL
T	NULL
cells	NULL
in	NULL
this	NULL
patient	NULL
is	NULL
inferred	NULL
by	NULL
the	NULL
disappearance	NULL
of	NULL
one	NULL
allele	NULL
after	NULL
digestion	NULL
of	NULL
granulocyte	NULL
but	NULL
not	NULL
T-cell	NULL
DNA	NULL
with	NULL
Hha	NULL
I	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Patient	NULL
JM	NULL
.	NULL

Neither	NULL
granulocyte	NULL
nor	NULL
T-cell	NULL
DNA	NULL
displayed	NULL
allele-specific	NULL
digestion	NULL
with	NULL
Hha	NULL
I	NULL
,	NULL
suggesting	NULL
that	NULL
both	NULL
cell	NULL
types	NULL
are	NULL
polyclonal	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Patient	NULL
PS	NULL
.	NULL

Allele-specific	NULL
digestion	NULL
of	NULL
granulocyte	NULL
but	NULL
not	NULL
T-cell	NULL
DNA	NULL
from	NULL
a	NULL
patient	NULL
with	NULL
two	NULL
HUMARA	NULL
alleles	NULL
separated	NULL
by	NULL
one	NULL
trinucleotide	NULL
repeat	NULL
.	NULL

For	NULL
an	NULL
explanation	NULL
of	NULL
similar	NULL
patterns	NULL
,	NULL
see	NULL
the	NULL
study	NULL
by	NULL
Hughes	NULL
.	NULL
``	NULL

(	NULL
D	NULL
)	NULL
Patient	NULL
SS	NULL
.	NULL

Allele-specific	NULL
digestion	NULL
of	NULL
both	NULL
granulocyte	NULL
and	NULL
T-cell	NULL
DNA	NULL
from	NULL
a	NULL
patient	NULL
with	NULL
two	NULL
HUMARA	NULL
alleles	NULL
separated	NULL
by	NULL
one	NULL
trinucleotide	NULL
repeat	NULL
.	NULL

Densitometric	NULL
analysis	NULL
of	NULL
the	NULL
results	NULL
showed	NULL
that	NULL
the	NULL
intensity	NULL
of	NULL
the	NULL
upper	NULL
allele	NULL
exhibited	NULL
a	NULL
linear	NULL
relationship	NULL
with	NULL
the	NULL
percentage	NULL
of	NULL
Hha	NULL
I-digested	NULL
DNA	NULL
in	NULL
the	NULL
sample	NULL
(	NULL
Fig	NULL
4B	NULL
)	NULL
.	NULL

All	NULL
female	NULL
patients	NULL
(	NULL
n	NULL
=	NULL
31	NULL
)	NULL
were	NULL
included	NULL
in	NULL
the	NULL
HUMARA	NULL
clonality	NULL
analysis	NULL
(	NULL
the	NULL
remainder	NULL
21	NULL
patients	NULL
were	NULL
male	NULL
)	NULL
.	NULL

Three	NULL
of	NULL
these	NULL
patients	NULL
had	NULL
idiopathic	NULL
myelofibrosis	NULL
(	NULL
patients	NULL
HP	NULL
,	NULL
DR	NULL
,	NULL
DH	NULL
)	NULL
and	NULL
the	NULL
rest	NULL
had	NULL
polycythemia	NULL
vera	NULL
.	NULL

Four	NULL
of	NULL
the	NULL
31	NULL
patients	NULL
were	NULL
homozygous	NULL
and	NULL
therefore	NULL
unin-formative	NULL
.	NULL

Of	NULL
the	NULL
remaining	NULL
27	NULL
patients	NULL
,	NULL
21	NULL
displayed	NULL
well-separated	NULL
alleles	NULL
,	NULL
the	NULL
intensity	NULL
of	NULL
which	NULL
could	NULL
be	NULL
analyzed	NULL
by	NULL
densitometry	NULL
(	NULL
see	NULL
Table	NULL
3	NULL
)	NULL
.	NULL

An	NULL
allele	NULL
intensity	NULL
ratio	NULL
of	NULL
1:3	NULL
has	NULL
previously	NULL
been	NULL
used	NULL
as	NULL
a	NULL
practical	NULL
(	NULL
albeit	NULL
arbitrary	NULL
)	NULL
threshold	NULL
for	NULL
assessing	NULL
the	NULL
clonality	NULL
of	NULL
tumor	NULL
cell	NULL
popula-tions	NULL
.	NULL
``	NULL

''	NULL
``	NULL
'	NULL
If	NULL
there	NULL
is	NULL
random	NULL
X-chromosome	NULL
inactivation	NULL
(	NULL
T-cell	NULL
allele	NULL
ratio	NULL
=	NULL
1	NULL
)	NULL
,	NULL
a	NULL
granulocyte	NULL
allele	NULL
ratio	NULL
of	NULL
1:3	NULL
would	NULL
correspond	NULL
to	NULL
50	NULL
%	NULL
clonal	NULL
granulocytes	NULL
.	NULL

In	NULL
17	NULL
of	NULL
21	NULL
informative	NULL
patients	NULL
that	NULL
were	NULL
assessed	NULL
densitometrically	NULL
,	NULL
the	NULL
proportion	NULL
of	NULL
clonal	NULL
granulocytes	NULL
exceeded	NULL
50	NULL
%	NULL
(	NULL
Fig	NULL
5A	NULL
)	NULL
.	NULL

In	NULL
4	NULL
patients	NULL
most	NULL
or	NULL
all	NULL
of	NULL
the	NULL
granulocytes	NULL
appeared	NULL
polyclonal	NULL
(	NULL
Fig	NULL
5B	NULL
)	NULL
.	NULL

Six	NULL
patients	NULL
exhibited	NULL
alleles	NULL
too	NULL
similar	NULL
in	NULL
size	NULL
to	NULL
allow	NULL
accurate	NULL
densitometric	NULL
analysis	NULL
,	NULL
and	NULL
so	NULL
the	NULL
autoradiographs	NULL
were	NULL
assessed	NULL
visually	NULL
.	NULL

In	NULL
4	NULL
of	NULL
these	NULL
patients	NULL
(	NULL
including	NULL
the	NULL
2	NULL
female	NULL
patients	NULL
with	NULL
loss	NULL
of	NULL
heterozygosity	NULL
for	NULL
20q	NULL
markers	NULL
)	NULL
preferential	NULL
digestion	NULL
of	NULL
one	NULL
allele	NULL
was	NULL
clearly	NULL
observed	NULL
in	NULL
granulocytes	NULL
but	NULL
not	NULL
T	NULL
cells	NULL
(	NULL
Fig	NULL
5C	NULL
)	NULL
.	NULL

In	NULL
one	NULL
patient	NULL
no	NULL
preferential	NULL
allele	NULL
loss	NULL
was	NULL
seen	NULL
in	NULL
either	NULL
granulocytes	NULL
or	NULL
T	NULL
cells	NULL
(	NULL
polyclonal	NULL
pattern	NULL
)	NULL
and	NULL
in	NULL
the	NULL
remaining	NULL
patient	NULL
preferential	NULL
allele	NULL
loss	NULL
was	NULL
seen	NULL
in	NULL
both	NULL
granulocytes	NULL
and	NULL
T	NULL
cells	NULL
(	NULL
``	NULL
skewed	NULL
``	NULL
'	NULL
pattern	NULL
)	NULL
(	NULL
Fig	NULL
5D	NULL
)	NULL
.	NULL

This	NULL
result	NULL
would	NULL
be	NULL
consistent	NULL
with	NULL
either	NULL
skewed	NULL
Lyonization	NULL
or	NULL
the	NULL
production	NULL
of	NULL
both	NULL
granulocytes	NULL
and	NULL
T	NULL
cells	NULL
by	NULL
the	NULL
malignant	NULL
progenitors	NULL
in	NULL
this	NULL
patient	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
our	NULL
results	NULL
show	NULL
that	NULL
the	NULL
majority	NULL
of	NULL
granulocytes	NULL
were	NULL
clonally	NULL
derived	NULL
in	NULL
21	NULL
of	NULL
27	NULL
informative	NULL
patients	NULL
and	NULL
were	NULL
mostly	NULL
polyclonal	NULL
in	NULL
5	NULL
patients	NULL
.	NULL

Therefore	NULL
,	NULL
our	NULL
data	NULL
suggest	NULL
that	NULL
in	NULL
most	NULL
patients	NULL
the	NULL
failure	NULL
to	NULL
detect	NULL
loss	NULL
of	NULL
heterozygosity	NULL
for	NULL
loci	NULL
on	NULL
chromosome	NULL
20q	NULL
did	NULL
not	NULL
reflect	NULL
masking	NULL
by	NULL
normal	NULL
granulocytes	NULL
.	NULL

DISCUSSION	NULL
In	NULL
this	NULL
report	NULL
we	NULL
have	NULL
searched	NULL
for	NULL
loss	NULL
of	NULL
heterozygosity	NULL
within	NULL
the	NULL
common	NULL
deleted	NULL
region	NULL
on	NULL
chromosome	NULL
20q	NULL
in	NULL
samples	NULL
from	NULL
48	NULL
patients	NULL
with	NULL
polycythemia	NULL
vera	NULL
and	NULL
4	NULL
patients	NULL
with	NULL
primary	NULL
myelofibrosis	NULL
.	NULL

Seventeen	NULL
microsatellite	NULL
markers	NULL
spaced	NULL
at	NULL
approximately	NULL
1-	NULL
to	NULL
3-cM	NULL
intervals	NULL
were	NULL
used	NULL
.	NULL

Only	NULL
four	NULL
samples	NULL
displayed	NULL
loss	NULL
of	NULL
heterozygosity	NULL
and	NULL
in	NULL
each	NULL
case	NULL
the	NULL
underlying	NULL
mechanism	NULL
was	NULL
a	NULL
previously	NULL
undetected	NULL
interstitial	NULL
deletion	NULL
.	NULL

These	NULL
results	NULL
show	NULL
that	NULL
in	NULL
polycythemia	NULL
vera	NULL
,	NULL
as	NULL
in	NULL
MDS	NULL
,	NULL
mitotic	NULL
recombination	NULL
is	NULL
rare	NULL
.	NULL

Chromosome	NULL
20	NULL
is	NULL
a	NULL
small	NULL
chromosome	NULL
and	NULL
the	NULL
detection	NULL
of	NULL
small	NULL
deletions	NULL
using	NULL
conventional	NULL
cytogenetics	NULL
is	NULL
technically	NULL
demanding	NULL
.	NULL

Therefore	NULL
,	NULL
it	NULL
has	NULL
been	NULL
proposed	NULL
that	NULL
small	NULL
submicroscopic	NULL
deletions	NULL
may	NULL
exist	NULL
but	NULL
escape	NULL
detection	NULL
.	NULL

Our	NULL
data	NULL
suggest	NULL
that	NULL
such	NULL
deletions	NULL
are	NULL
,	NULL
in	NULL
fact	NULL
,	NULL
rare	NULL
.	NULL

One	NULL
possible	NULL
explanation	NULL
would	NULL
be	NULL
the	NULL
presence	NULL
of	NULL
widely	NULL
spaced	NULL
hotspots	NULL
for	NULL
chromosome	NULL
breakage	NULL
.	NULL

However	NULL
,	NULL
this	NULL
seems	NULL
unlikely	NULL
because	NULL
there	NULL
is	NULL
considerable	NULL
heterogeneity	NULL
of	NULL
both	NULL
centromeric	NULL
and	NULL
telomeric	NULL
breakpoints	NULL
.	NULL
'	NULL

''	NULL
Moreover	NULL
,	NULL
it	NULL
should	NULL
be	NULL
emphasized	NULL
that	NULL
our	NULL
data	NULL
do	NULL
not	NULL
exclude	NULL
the	NULL
existence	NULL
of	NULL
very	NULL
small	NULL
deletions	NULL
(	NULL
<	NULL
1	NULL
to	NULL
3	NULL
cM	NULL
)	NULL
which	NULL
would	NULL
be	NULL
beyond	NULL
the	NULL
resolution	NULL
of	NULL
this	NULL
study	NULL
.	NULL

One	NULL
potential	NULL
reason	NULL
for	NULL
our	NULL
failure	NULL
to	NULL
detect	NULL
loss	NULL
of	NULL
heterozygosity	NULL
in	NULL
most	NULL
patients	NULL
might	NULL
have	NULL
been	NULL
the	NULL
presence	NULL
of	NULL
significant	NULL
numbers	NULL
of	NULL
polyclonal	NULL
normal	NULL
granulocytes	NULL
.	NULL

Gilliland	NULL
et	NULL
al	NULL
``	NULL
``	NULL
reported	NULL
PB	NULL
granulocytes	NULL
that	NULL
were	NULL
polyclonal	NULL
in	NULL
one	NULL
of	NULL
three	NULL
patients	NULL
with	NULL
polycythemia	NULL
vera	NULL
.	NULL

More	NULL
MECHANISMS	NULL
FOR	NULL
LOH	NULL
ON	NULL
CHROMOSOME	NULL
20q	NULL
over	NULL
,	NULL
in	NULL
further	NULL
studies	NULL
,	NULL
total	NULL
PB	NULL
leukocytes	NULL
or	NULL
bone	NULL
marrow	NULL
nucleated	NULL
cells	NULL
gave	NULL
nonclonal	NULL
patterns	NULL
in	NULL
2	NULL
of	NULL
26	NULL
patients	NULL
with	NULL
polycythemia	NULL
.	NULL
``	NULL

The	NULL
presence	NULL
of	NULL
significant	NULL
numbers	NULL
of	NULL
polyclonal	NULL
granulocytes	NULL
would	NULL
mask	NULL
loss	NULL
of	NULL
heterozygosity	NULL
occurring	NULL
in	NULL
a	NULL
subpopulation	NULL
of	NULL
clonally	NULL
derived	NULL
granulocytes	NULL
.	NULL

Previous	NULL
mixing	NULL
experiments	NULL
have	NULL
assessed	NULL
the	NULL
sensitivity	NULL
of	NULL
microsatellite	NULL
PCR	NULL
for	NULL
the	NULL
detection	NULL
of	NULL
a	NULL
deletion	NULL
carried	NULL
by	NULL
a	NULL
subpopulation	NULL
of	NULL
cells	NULL
.	NULL

These	NULL
studies	NULL
showed	NULL
that	NULL
visual	NULL
inspection	NULL
of	NULL
autoradiographs	NULL
could	NULL
detect	NULL
reduced	NULL
intensity	NULL
of	NULL
one	NULL
allele	NULL
if	NULL
the	NULL
deletion	NULL
were	NULL
present	NULL
in	NULL
=	NULL
>	NULL
40	NULL
%	NULL
of	NULL
these	NULL
cells	NULL
.	NULL
``	NULL

Therefore	NULL
,	NULL
it	NULL
was	NULL
important	NULL
to	NULL
assess	NULL
the	NULL
clonality	NULL
of	NULL
PB	NULL
granulocytes	NULL
in	NULL
our	NULL
patients	NULL
.	NULL

To	NULL
address	NULL
this	NULL
issue	NULL
we	NULL
have	NULL
used	NULL
the	NULL
HUMARA	NULL
assay	NULL
to	NULL
estimate	NULL
the	NULL
proportion	NULL
of	NULL
clonally	NULL
derived	NULL
granulocytes	NULL
in	NULL
all	NULL
female	NULL
patients	NULL
included	NULL
in	NULL
this	NULL
study	NULL
.	NULL

Five	NULL
of	NULL
27	NULL
informative	NULL
patients	NULL
exhibited	NULL
polyclonal	NULL
granulocytes	NULL
.	NULL

In	NULL
21	NULL
of	NULL
these	NULL
informative	NULL
patients	NULL
,	NULL
at	NULL
least	NULL
50	NULL
%	NULL
of	NULL
the	NULL
granulocytes	NULL
were	NULL
clonally	NULL
derived	NULL
.	NULL

These	NULL
results	NULL
show	NULL
that	NULL
,	NULL
in	NULL
the	NULL
majority	NULL
of	NULL
patients	NULL
presented	NULL
here	NULL
,	NULL
the	NULL
failure	NULL
to	NULL
detect	NULL
loss	NULL
of	NULL
heterozygosity	NULL
can	NULL
not	NULL
be	NULL
attributed	NULL
to	NULL
the	NULL
presence	NULL
of	NULL
normal	NULL
polyclonal	NULL
granulocytes	NULL
.	NULL

One	NULL
patient	NULL
,	NULL
in	NULL
whom	NULL
densitometric	NULL
analysis	NULL
of	NULL
results	NULL
was	NULL
not	NULL
possible	NULL
,	NULL
displayed	NULL
unilateral	NULL
patterns	NULL
of	NULL
X	NULL
inactivation	NULL
in	NULL
both	NULL
granulocytes	NULL
and	NULL
T	NULL
cells	NULL
.	NULL

Unilateral	NULL
X	NULL
inactivation	NULL
of	NULL
T-cell	NULL
DNA	NULL
may	NULL
reflect	NULL
skewed	NULL
Lyonization	NULL
or	NULL
involvement	NULL
of	NULL
T	NULL
cells	NULL
in	NULL
the	NULL
malignant	NULL
clone	NULL
.	NULL

Previous	NULL
reports	NULL
have	NULL
shown	NULL
monoclonal	NULL
derivation	NULL
of	NULL
PB	NULL
leukocytes	NULL
in	NULL
24	NULL
of	NULL
26	NULL
patients	NULL
with	NULL
polycythemia	NULL
vera	NULL
.	NULL
``	NULL

''	NULL
``	NULL
``	NULL
``	NULL
``	NULL
However	NULL
,	NULL
in	NULL
view	NULL
of	NULL
the	NULL
heterogeneity	NULL
of	NULL
X	NULL
inactivation	NULL
patterns	NULL
in	NULL
different	NULL
tissues	NULL
,	NULL
``	NULL
it	NULL
has	NULL
been	NULL
shown	NULL
that	NULL
it	NULL
is	NULL
important	NULL
to	NULL
use	NULL
T	NULL
cells	NULL
as	NULL
a	NULL
control	NULL
to	NULL
exclude	NULL
skewed	NULL
Lyonization	NULL
.	NULL
``	NULL

''	NULL
Before	NULL
this	NULL
report	NULL
,	NULL
purified	NULL
granulocytes	NULL
and	NULL
T	NULL
cells	NULL
have	NULL
been	NULL
studied	NULL
in	NULL
only	NULL
a	NULL
few	NULL
pa-tients	NULL
.	NULL

``	NULL
``	NULL
``	NULL
*	NULL
``	NULL
Granulocytes	NULL
were	NULL
clonal	NULL
and	NULL
T	NULL
cells	NULL
polyclonal	NULL
in	NULL
10	NULL
patients	NULL
,	NULL
both	NULL
granulocytes	NULL
and	NULL
T	NULL
cells	NULL
were	NULL
polyclonal	NULL
in	NULL
1	NULL
patient	NULL
,	NULL
and	NULL
a	NULL
skewed	NULL
pattern	NULL
was	NULL
seen	NULL
in	NULL
both	NULL
granulocytes	NULL
and	NULL
T	NULL
cells	NULL
in	NULL
1	NULL
patient	NULL
.	NULL

Two	NULL
additional	NULL
patients	NULL
reported	NULL
by	NULL
Gilliland	NULL
et	NULL
al	NULL
``	NULL
``	NULL
demonstrated	NULL
unilateral	NULL
X	NULL
inactivation	NULL
of	NULL
purified	NULL
granulocytes	NULL
but	NULL
the	NULL
clonality	NULL
of	NULL
lymphoid	NULL
cells	NULL
was	NULL
not	NULL
studied	NULL
.	NULL

In	NULL
none	NULL
of	NULL
these	NULL
reports	NULL
was	NULL
an	NULL
attempt	NULL
made	NULL
to	NULL
estimate	NULL
the	NULL
proportion	NULL
of	NULL
clonal	NULL
cells	NULL
.	NULL

In	NULL
the	NULL
work	NULL
reported	NULL
here	NULL
,	NULL
no	NULL
difference	NULL
in	NULL
the	NULL
size	NULL
of	NULL
the	NULL
microsatellite	NULL
alleles	NULL
amplified	NULL
from	NULL
granulocytes	NULL
and	NULL
T	NULL
cells	NULL
was	NULL
detected	NULL
in	NULL
a	NULL
total	NULL
of	NULL
880	NULL
separate	NULL
comparisons	NULL
.	NULL

Therefore	NULL
,	NULL
our	NULL
data	NULL
show	NULL
that	NULL
genetic	NULL
instability	NULL
is	NULL
extremely	NULL
rare	NULL
in	NULL
PV	NULL
.	NULL

There	NULL
is	NULL
relatively	NULL
little	NULL
information	NULL
available	NULL
about	NULL
microsatellite	NULL
instability	NULL
in	NULL
hematologic	NULL
malignancies	NULL
.	NULL

In	NULL
a	NULL
study	NULL
of	NULL
21	NULL
patients	NULL
with	NULL
lymphomas	NULL
and	NULL
acute	NULL
leukemias	NULL
,	NULL
both	NULL
lymphoblastic	NULL
and	NULL
myeloid	NULL
,	NULL
using	NULL
10	NULL
microsatellite	NULL
markers	NULL
,	NULL
``	NULL
microsatellite	NULL
instability	NULL
was	NULL
only	NULL
demonstrated	NULL
in	NULL
one	NULL
case	NULL
of	NULL
AML	NULL
and	NULL
two	NULL
patients	NULL
with	NULL
B-cell	NULL
lymphoid	NULL
malignancies	NULL
(	NULL
Burkitt	NULL
's	NULL
lymphoma	NULL
and	NULL
B-cell	NULL
acute	NULL
lymphoblastic	NULL
leukemia	NULL
)	NULL
.	NULL

Kaneko	NULL
et	NULL
al	NULL
``	NULL
``	NULL
reported	NULL
6	NULL
patients	NULL
with	NULL
MDS	NULL
,	NULL
two	NULL
of	NULL
whom	NULL
exhibited	NULL
microsatellite	NULL
instability	NULL
at	NULL
4	NULL
of	NULL
4	NULL
loci	NULL
,	NULL
whereas	NULL
this	NULL
was	NULL
not	NULL
observed	NULL
in	NULL
the	NULL
other	NULL
4	NULL
patients	NULL
,	NULL
even	NULL
using	NULL
samples	NULL
obtained	NULL
after	NULL
leukemic	NULL
evolu-tion	NULL
.	NULL

Furthermore	NULL
,	NULL
in	NULL
chronic	NULL
myeloid	NULL
leukemia	NULL
,	NULL
a	NULL
high	NULL
incidence	NULL
of	NULL
genetic	NULL
instability	NULL
has	NULL
been	NULL
reported	NULL
in	NULL
the	NULL
accelerated	NULL
and	NULL
blastic	NULL
phase	NULL
but	NULL
not	NULL
the	NULL
chronic	NULL
phase	NULL
of	NULL
the	NULL
disease	NULL
.	NULL
``	NULL

2697	NULL
In	NULL
summary	NULL
,	NULL
our	NULL
data	NULL
show	NULL
that	NULL
allele	NULL
loss	NULL
on	NULL
chromosome	NULL
20q	NULL
in	NULL
patients	NULL
with	NULL
PV	NULL
does	NULL
not	NULL
commonly	NULL
involve	NULL
mitotic	NULL
recombination	NULL
or	NULL
chromosome	NULL
loss	NULL
and	NULL
that	NULL
microsatellite	NULL
instability	NULL
is	NULL
extremely	NULL
rare	NULL
in	NULL
this	NULL
disorder	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
HUMARA	NULL
assay	NULL
was	NULL
used	NULL
to	NULL
show	NULL
that	NULL
most	NULL
PB	NULL
granulocytes	NULL
were	NULL
clonal	NULL
in	NULL
the	NULL
majority	NULL
of	NULL
female	NULL
patients	NULL
and	NULL
so	NULL
the	NULL
failure	NULL
to	NULL
detect	NULL
loss	NULL
of	NULL
heterozygosity	NULL
can	NULL
not	NULL
be	NULL
attributed	NULL
to	NULL
the	NULL
presence	NULL
of	NULL
normal	NULL
polyclonal	NULL
granulocytes	NULL
.	NULL

ACKNOWLEDGMENT	NULL
We	NULL
are	NULL
grateful	NULL
to	NULL
Dr	NULL
Maria	NULL
Messinezy	NULL
(	NULL
Department	NULL
of	NULL
Haematology	NULL
,	NULL
St	NULL
Thomas	NULL
's	NULL
Hospital	NULL
,	NULL
London	NULL
,	NULL
UK	NULL
)	NULL
for	NULL
providing	NULL
clinical	NULL
samples	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Kay	NULL
HEM	NULL
,	NULL
Lawler	NULL
SD	NULL
,	NULL
Millard	NULL
RE	NULL
:	NULL
The	NULL
chromosomes	NULL
in	NULL
polycythaemia	NULL
vera	NULL
.	NULL

Br	NULL
J	NULL
Haematol	NULL
12:507	NULL
,	NULL
1966	NULL
2	NULL
.	NULL

Rege-Cambrin	NULL
G	NULL
,	NULL
Mecueci	NULL
C	NULL
,	NULL
Tricot	NULL
G	NULL
,	NULL
Michaux	NULL
JL	NULL
,	NULL
Louwagie	NULL
A	NULL
,	NULL
Van	NULL
Hove	NULL
W	NULL
,	NULL
Francart	NULL
H	NULL
,	NULL
van	NULL
den	NULL
Berghe	NULL
H	NULL
:	NULL
A	NULL
chromosomal	NULL
profile	NULL
of	NULL
polycythaemia	NULL
.	NULL

Cancer	NULL
Genet	NULL
Cytogenet	NULL
25:235	NULL
,	NULL
1987	NULL
3	NULL
.	NULL

Swolin	NULL
B	NULL
,	NULL
Weinfeld	NULL
A	NULL
,	NULL
Westin	NULL
J	NULL
:	NULL
A	NULL
prospective	NULL
long-term	NULL
cytogenetic	NULL
study	NULL
in	NULL
polycythaemia	NULL
vera	NULL
in	NULL
relation	NULL
to	NULL
treatment	NULL
and	NULL
clinical	NULL
course	NULL
.	NULL

Blood	NULL
72:386	NULL
,	NULL
1988	NULL
4	NULL
.	NULL

Diez-Martin	NULL
JL	NULL
,	NULL
Graham	NULL
DL	NULL
,	NULL
Pettit	NULL
RM	NULL
,	NULL
Dewald	NULL
GW	NULL
:	NULL
Chromosome	NULL
studies	NULL
in	NULL
104	NULL
patients	NULL
with	NULL
polycythaemia	NULL
vera	NULL
.	NULL

Mayo	NULL
Clin	NULL
Proc	NULL
66:287	NULL
,	NULL
1991	NULL
5	NULL
.	NULL

Mertens	NULL
F	NULL
,	NULL
Johanssen	NULL
B	NULL
,	NULL
Heim	NULL
S	NULL
,	NULL
Kristoffersson	NULL
U	NULL
,	NULL
Mitelman	NULL
F	NULL
:	NULL
Karyotypic	NULL
patterns	NULL
in	NULL
chronic	NULL
myeloproliferative	NULL
disorders	NULL
:	NULL
Report	NULL
on	NULL
74	NULL
cases	NULL
and	NULL
review	NULL
of	NULL
the	NULL
literature	NULL
.	NULL

Leukemia	NULL
5:214	NULL
,	NULL
1991	NULL
6	NULL
.	NULL

Knapp	NULL
RH	NULL
,	NULL
Dewald	NULL
GW	NULL
,	NULL
Pierre	NULL
RV	NULL
:	NULL
Cytogenetic	NULL
studies	NULL
in	NULL
174	NULL
consecutive	NULL
patients	NULL
with	NULL
preleukemia	NULL
or	NULL
myelodysplastic	NULL
syndromes	NULL
.	NULL

Mayo	NULL
Clin	NULL
Proc	NULL
60:507	NULL
,	NULL
1985	NULL
7	NULL
.	NULL

Mufti	NULL
GJ	NULL
:	NULL
Chromosomal	NULL
deletions	NULL
in	NULL
the	NULL
myelodysplastic	NULL
syn-drome	NULL
.	NULL

Leuk	NULL
Res	NULL
16:35	NULL
,	NULL
1992	NULL
8	NULL
.	NULL

Mittelman	NULL
F	NULL
:	NULL
Catalog	NULL
of	NULL
Chromosome	NULL
Aberrations	NULL
in	NULL
Cancer	NULL
.	NULL

New	NULL
York	NULL
,	NULL
NY	NULL
,	NULL
Wiley-Liss	NULL
,	NULL
1991	NULL
9	NULL
.	NULL

Nacheva	NULL
E	NULL
,	NULL
Holloway	NULL
T	NULL
,	NULL
White	NULL
N	NULL
,	NULL
Carter	NULL
N	NULL
,	NULL
Grace	NULL
C	NULL
,	NULL
Green	NULL
AR	NULL
:	NULL
;	NULL
Characterization	NULL
of	NULL
chromosome	NULL
20q	NULL
deletions	NULL
in	NULL
patients	NULL
with	NULL
myeloproliferative	NULL
disorders	NULL
or	NULL
myelodysplastic	NULL
syndromes	NULL
.	NULL

Cancer	NULL
Genet	NULL
Cytogenet	NULL
80:87	NULL
,	NULL
1995	NULL
10	NULL
.	NULL

Asimakopoulos	NULL
FA	NULL
,	NULL
White	NULL
NJ	NULL
,	NULL
Nacheva	NULL
E	NULL
,	NULL
Green	NULL
AR	NULL
:	NULL
Molecular	NULL
analysis	NULL
of	NULL
chromosome	NULL
20q	NULL
deletions	NULL
associated	NULL
with	NULL
myeloproliferative	NULL
disorders	NULL
and	NULL
myelodysplastic	NULL
syndromes	NULL
.	NULL

Blood	NULL
843086	NULL
,	NULL
1994	NULL
11	NULL
.	NULL

Ponder	NULL
B	NULL
:	NULL
Gene	NULL
losses	NULL
in	NULL
human	NULL
tumours	NULL
.	NULL

Nature	NULL
335:400	NULL
,	NULL
1988	NULL
12	NULL
.	NULL

Patterson	NULL
H	NULL
:	NULL
Approaches	NULL
to	NULL
proto-oncogene	NULL
and	NULL
tumour	NULL
suppressor	NULL
gene	NULL
identification	NULL
.	NULL

Eur	NULL
J	NULL
Cancer	NULL
28A:278	NULL
,	NULL
1992	NULL
13	NULL
.	NULL

Lasko	NULL
D	NULL
,	NULL
Cavenee	NULL
W	NULL
,	NULL
Nordenskjold	NULL
M	NULL
:	NULL
Loss	NULL
of	NULL
constitutional	NULL
heterozygosity	NULL
in	NULL
human	NULL
cancer	NULL
.	NULL

Annu	NULL
Rev	NULL
Genet	NULL
25:281	NULL
,	NULL
1991	NULL
14	NULL
.	NULL

Levine	NULL
A	NULL
:	NULL
The	NULL
tumor	NULL
suppressor	NULL
genes	NULL
.	NULL

Annu	NULL
Rev	NULL
Biochem	NULL
62:623	NULL
,	NULL
1993	NULL
15	NULL
.	NULL

Hansen	NULL
MF	NULL
,	NULL
Cavenee	NULL
WK	NULL
:	NULL
Genetics	NULL
of	NULL
cancer	NULL
predisposition	NULL
.	NULL

Cancer	NULL
Res	NULL
47:5518	NULL
,	NULL
1987	NULL
16	NULL
.	NULL

James	NULL
CD	NULL
,	NULL
Carlbom	NULL
E	NULL
,	NULL
Dumanski	NULL
JP	NULL
,	NULL
Hansen	NULL
M	NULL
,	NULL
Nordenskjold	NULL
M	NULL
,	NULL
Collins	NULL
VP	NULL
,	NULL
Cavenee	NULL
WK	NULL
:	NULL
Clonal	NULL
genomic	NULL
alterations	NULL
in	NULL
glioma	NULL
malignancy	NULL
stages	NULL
.	NULL

Cancer	NULL
Res	NULL
48:5546	NULL
,	NULL
1988	NULL
17	NULL
.	NULL

James	NULL
CD	NULL
,	NULL
Carlbom	NULL
E	NULL
,	NULL
Collins	NULL
VP	NULL
,	NULL
Cavenee	NULL
WK	NULL
:	NULL
Mitotic	NULL
recombination	NULL
of	NULL
chromosome	NULL
17	NULL
in	NULL
astrocytomas	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
86:2858	NULL
,	NULL
1989	NULL
18	NULL
.	NULL

Mulligan	NULL
LM	NULL
,	NULL
Matlashewski	NULL
GJ	NULL
,	NULL
Scrable	NULL
HJ	NULL
,	NULL
Cavenee	NULL
WK	NULL
:	NULL
Mechanisms	NULL
of	NULL
p53	NULL
loss	NULL
in	NULL
human	NULL
sarcomas	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
87:5863	NULL
,	NULL
1990	NULL
2698	NULL
19	NULL
.	NULL

Scrable	NULL
HJ	NULL
,	NULL
Witte	NULL
DP	NULL
,	NULL
Lampkin	NULL
BC	NULL
,	NULL
Cavenee	NULL
WK	NULL
:	NULL
Chromosomal	NULL
localisation	NULL
of	NULL
the	NULL
human	NULL
rhabdomyosarcoma	NULL
locus	NULL
by	NULL
mitotic	NULL
recombination	NULL
mapping	NULL
.	NULL

Nature	NULL
329:645	NULL
,	NULL
1987	NULL
20	NULL
.	NULL

Wooster	NULL
R	NULL
,	NULL
Cleton-Jansen	NULL
AM	NULL
,	NULL
Collins	NULL
N	NULL
,	NULL
Mangion	NULL
J	NULL
,	NULL
Cor-nelis	NULL
RS	NULL
,	NULL
Coper	NULL
CS	NULL
,	NULL
Gusterson	NULL
BA	NULL
,	NULL
Ponder	NULL
BAJ	NULL
,	NULL
von	NULL
Deimling	NULL
A	NULL
,	NULL
Wiestler	NULL
OD	NULL
,	NULL
Cornelisse	NULL
CJ	NULL
,	NULL
Devilee	NULL
P	NULL
,	NULL
Stratton	NULL
MR	NULL
:	NULL
Instability	NULL
of	NULL
short	NULL
tandem	NULL
repeats	NULL
(	NULL
microsatellites	NULL
)	NULL
in	NULL
human	NULL
cancers	NULL
.	NULL

Nature	NULL
Genet	NULL
6:152	NULL
,	NULL
1994	NULL
21	NULL
.	NULL

Aaltonen	NULL
LA	NULL
,	NULL
Peltomaki	NULL
P	NULL
,	NULL
Leach	NULL
FS	NULL
,	NULL
Sistonen	NULL
P	NULL
,	NULL
Pylkkanen	NULL
L	NULL
,	NULL
Mecklin	NULL
JP	NULL
,	NULL
Jarvinen	NULL
H	NULL
,	NULL
Powell	NULL
SM	NULL
,	NULL
Jen	NULL
J	NULL
,	NULL
Hamilton	NULL
R	NULL
,	NULL
Petersen	NULL
GM	NULL
,	NULL
Kinzler	NULL
KW	NULL
,	NULL
Vogelstein	NULL
B	NULL
,	NULL
de	NULL
la	NULL
Chapelle	NULL
A	NULL
:	NULL
Clues	NULL
to	NULL
the	NULL
pathogenesis	NULL
of	NULL
familial	NULL
colorectal	NULL
cancer	NULL
.	NULL

Science	NULL
260:812	NULL
,	NULL
1993	NULL
22	NULL
.	NULL

Robledo	NULL
M	NULL
,	NULL
Martinez	NULL
B	NULL
,	NULL
Arranz	NULL
E	NULL
,	NULL
Trujillo	NULL
MJ	NULL
,	NULL
Gonzalez	NULL
Ageitos	NULL
A	NULL
,	NULL
Rivas	NULL
C	NULL
,	NULL
Benitez	NULL
J	NULL
:	NULL
Genetic	NULL
instability	NULL
of	NULL
microsatellites	NULL
in	NULL
hematological	NULL
neoplasms	NULL
.	NULL

Leukemia	NULL
9:960	NULL
,	NULL
1995	NULL
23	NULL
.	NULL

Hubner	NULL
G	NULL
,	NULL
Battmer	NULL
K	NULL
,	NULL
Paaz	NULL
U	NULL
,	NULL
Link	NULL
H	NULL
:	NULL
Monitoring	NULL
of	NULL
relapse	NULL
and	NULL
remission	NULL
in	NULL
acute	NULL
leukaemias	NULL
by	NULL
DNA	NULL
fingerprint	NULL
analysis	NULL
.	NULL

Br	NULL
J	NULL
Haematol	NULL
85:320	NULL
,	NULL
1993	NULL
24	NULL
.	NULL

Kaneko	NULL
H	NULL
,	NULL
Horiike	NULL
S	NULL
,	NULL
Inazawa	NULL
J	NULL
,	NULL
Nakai	NULL
H	NULL
,	NULL
Misawa	NULL
S	NULL
:	NULL
Microsatellite	NULL
instability	NULL
is	NULL
an	NULL
early	NULL
event	NULL
in	NULL
the	NULL
myelodysplastic	NULL
syndrome	NULL
(	NULL
letter	NULL
)	NULL
.	NULL

Blood	NULL
86:1236	NULL
,	NULL
1995	NULL
25	NULL
.	NULL

Wada	NULL
C	NULL
,	NULL
Shionoya	NULL
S	NULL
,	NULL
Fujino	NULL
Y	NULL
,	NULL
Tokuhiro	NULL
H	NULL
,	NULL
Akahoshi	NULL
T	NULL
,	NULL
Uchida	NULL
T	NULL
,	NULL
Ohtani	NULL
H	NULL
:	NULL
Genomic	NULL
instability	NULL
of	NULL
microsatellite	NULL
repeats	NULL
and	NULL
its	NULL
association	NULL
with	NULL
the	NULL
evolution	NULL
of	NULL
chronic	NULL
myelogenous	NULL
leukemia	NULL
.	NULL

Blood	NULL
83:3449	NULL
,	NULL
1994	NULL
26	NULL
.	NULL

Neuman	NULL
WL	NULL
,	NULL
Rubin	NULL
CM	NULL
,	NULL
Rios	NULL
RB	NULL
,	NULL
Larson	NULL
RA	NULL
,	NULL
LeBeau	NULL
MM	NULL
,	NULL
Rowley	NULL
JD	NULL
,	NULL
Vardiman	NULL
JW	NULL
,	NULL
Schwartz	NULL
JL	NULL
,	NULL
Farber	NULL
RA	NULL
:	NULL
Chromosomal	NULL
loss	NULL
and	NULL
deletion	NULL
are	NULL
the	NULL
most	NULL
common	NULL
mechanisms	NULL
for	NULL
loss	NULL
of	NULL
heterozygosity	NULL
from	NULL
chromosomes	NULL
5	NULL
and	NULL
7	NULL
in	NULL
malignant	NULL
myeloid	NULL
disorders	NULL
.	NULL

Blood	NULL
79:1501	NULL
,	NULL
1992	NULL
27	NULL
.	NULL

Shepherd	NULL
L	NULL
,	NULL
Cameron	NULL
C	NULL
,	NULL
Galbraith	NULL
P	NULL
,	NULL
Windsor	NULL
S	NULL
,	NULL
Lillicrap	NULL
D	NULL
:	NULL
Absence	NULL
of	NULL
allelic	NULL
loss	NULL
on	NULL
chromosome	NULL
5q	NULL
by	NULL
RFLP	NULL
analysis	NULL
in	NULL
preleukaemia	NULL
.	NULL

Leuk	NULL
Res	NULL
15:297	NULL
,	NULL
1991	NULL
28	NULL
.	NULL

Allen	NULL
RC	NULL
,	NULL
Zogbi	NULL
Hy	NULL
,	NULL
Moseley	NULL
AB	NULL
,	NULL
Rosenblatt	NULL
HM	NULL
,	NULL
Belmont	NULL
JW	NULL
:	NULL
Methylation	NULL
of	NULL
Hpa	NULL
II	NULL
and	NULL
Hha	NULL
I	NULL
sites	NULL
near	NULL
the	NULL
polymorphic	NULL
CAG	NULL
repeat	NULL
in	NULL
the	NULL
human	NULL
androgen	NULL
receptor	NULL
gene	NULL
correlates	NULL
with	NULL
X	NULL
chromosome	NULL
inactivation	NULL
.	NULL

Am	NULL
J	NULL
Hum	NULL
Genet	NULL
51:1229	NULL
,	NULL
1992	NULL
29	NULL
.	NULL

Gyapay	NULL
G	NULL
,	NULL
Morissette	NULL
J	NULL
,	NULL
Vignal	NULL
A	NULL
,	NULL
Dib	NULL
C	NULL
,	NULL
Fizames	NULL
C	NULL
,	NULL
Millas-seau	NULL
P	NULL
,	NULL
Marc	NULL
S	NULL
,	NULL
Bernardi	NULL
G	NULL
,	NULL
Lathrop	NULL
M	NULL
,	NULL
Weissenbach	NULL
J	NULL
;	NULL
The	NULL
1993-94	NULL
GÃ©nÃ©thon	NULL
human	NULL
genetic	NULL
linkage	NULL
map	NULL
.	NULL

Nature	NULL
Genet	NULL
7:246	NULL
,	NULL
1994	NULL
30	NULL
.	NULL

Matise	NULL
TC	NULL
,	NULL
Prlin	NULL
M	NULL
,	NULL
Chakravarti	NULL
A	NULL
:	NULL
Automated	NULL
construction	NULL
of	NULL
genetic	NULL
linkage	NULL
maps	NULL
using	NULL
an	NULL
expert	NULL
system	NULL
(	NULL
Multimap	NULL
)	NULL
:	NULL
A	NULL
human	NULL
genome	NULL
linkage	NULL
map	NULL
.	NULL

Nature	NULL
Genet	NULL
6:384	NULL
,	NULL
1994	NULL
31	NULL
.	NULL

Buetow	NULL
KH	NULL
,	NULL
Weber	NULL
JL	NULL
,	NULL
Ludwigsen	NULL
S	NULL
,	NULL
Scherpbier-Heddema	NULL
T	NULL
,	NULL
Duyk	NULL
GM	NULL
,	NULL
Sheffield	NULL
VC	NULL
,	NULL
Wang	NULL
Z	NULL
,	NULL
Murray	NULL
JC	NULL
:	NULL
Integrated	NULL
human	NULL
genome-wide	NULL
maps	NULL
constructed	NULL
using	NULL
the	NULL
CEPH	NULL
reference	NULL
panel	NULL
.	NULL

Nature	NULL
Genet	NULL
6:391	NULL
,	NULL
1994	NULL
32	NULL
.	NULL

Wunderle	NULL
V	NULL
,	NULL
Dib	NULL
C	NULL
,	NULL
Fizames	NULL
C	NULL
,	NULL
Morissette	NULL
J	NULL
,	NULL
Hazan	NULL
J	NULL
,	NULL
Hansmann	NULL
I	NULL
,	NULL
Whitehouse	NULL
D	NULL
,	NULL
Vergnaud	NULL
G	NULL
,	NULL
Weissenbach	NULL
J	NULL
;	NULL
The	NULL
EURO-GEM	NULL
map	NULL
of	NULL
human	NULL
chromosome	NULL
20	NULL
.	NULL

Eur	NULL
J	NULL
Hum	NULL
Genet	NULL
2:242	NULL
,	NULL
1994	NULL
33	NULL
.	NULL

Rothchild	NULL
CB	NULL
,	NULL
Akots	NULL
G	NULL
,	NULL
Hayworth	NULL
R	NULL
,	NULL
Pettenati	NULL
MJ	NULL
,	NULL
Rao	NULL
PN	NULL
,	NULL
Wood	NULL
P	NULL
,	NULL
Stolz	NULL
F-M	NULL
,	NULL
Hansmann	NULL
I	NULL
,	NULL
Serino	NULL
K	NULL
,	NULL
Keith	NULL
TP	NULL
,	NULL
Fajans	NULL
SS	NULL
,	NULL
Bowden	NULL
DW	NULL
:	NULL
A	NULL
genetic	NULL
map	NULL
of	NULL
chromosome	NULL
20q12-q13.1	NULL
:	NULL
Multiple	NULL
highly	NULL
polymorphic	NULL
microsatellite	NULL
and	NULL
RFLP	NULL
markers	NULL
linked	NULL
to	NULL
the	NULL
ASIMAKOPQOULOS	NULL
ET	NULL
AL	NULL
maturity-onset	NULL
diabetes	NULL
of	NULL
the	NULL
young	NULL
(	NULL
MODY	NULL
)	NULL
locus	NULL
.	NULL

Am	NULL
J	NULL
Hum	NULL
Genet	NULL
52:110	NULL
,	NULL
1993	NULL
34	NULL
.	NULL

Smith	NULL
CL	NULL
,	NULL
Keith	NULL
T	NULL
,	NULL
Hansmann	NULL
I	NULL
,	NULL
Weissenbach	NULL
J	NULL
,	NULL
Asimakopoulos	NULL
FA	NULL
,	NULL
Bowden	NULL
DW	NULL
,	NULL
Deleuze	NULL
JF	NULL
,	NULL
Dutton	NULL
ER	NULL
,	NULL
Fasman	NULL
KH	NULL
,	NULL
Green	NULL
T	NULL
,	NULL
Hadchouel	NULL
M	NULL
,	NULL
Hazan	NULL
J	NULL
,	NULL
Hilgartner	NULL
S	NULL
,	NULL
Kingsbury	NULL
DK	NULL
,	NULL
Loder	NULL
B	NULL
,	NULL
Malafosse	NULL
A	NULL
,	NULL
Meunier-Rotival	NULL
M	NULL
,	NULL
Pearson	NULL
PL	NULL
,	NULL
Siracusa	NULL
LD	NULL
,	NULL
Steinlein	NULL
O	NULL
,	NULL
White	NULL
N	NULL
,	NULL
Williamson	NULL
CM	NULL
:	NULL
Report	NULL
of	NULL
the	NULL
first	NULL
international	NULL
workshop	NULL
on	NULL
human	NULL
chromosome	NULL
20	NULL
mapping	NULL
1993	NULL
.	NULL

Cytogenet	NULL
Cell	NULL
Genet	NULL
66:78	NULL
,	NULL
1994	NULL
35	NULL
.	NULL

Roulston	NULL
D	NULL
,	NULL
Espinosa	NULL
R	NULL
,	NULL
Stoffel	NULL
M	NULL
,	NULL
Bell	NULL
GI	NULL
,	NULL
LeBeau	NULL
MM	NULL
:	NULL
Molecular	NULL
genetics	NULL
of	NULL
myeloid	NULL
leukaemia	NULL
:	NULL
Identification	NULL
of	NULL
the	NULL
commonly	NULL
deleted	NULL
segment	NULL
of	NULL
chromosome	NULL
20	NULL
.	NULL

Blood	NULL
82:3424	NULL
,	NULL
1993	NULL
36	NULL
.	NULL

Gilliland	NULL
DG	NULL
,	NULL
Blanchard	NULL
KL	NULL
,	NULL
Levy	NULL
J	NULL
,	NULL
Perrin	NULL
S	NULL
,	NULL
Bunn	NULL
HF	NULL
:	NULL
Clonality	NULL
in	NULL
myeloproliferative	NULL
disorders	NULL
:	NULL
Analysis	NULL
by	NULL
means	NULL
of	NULL
the	NULL
polymerase	NULL
chain	NULL
reaction	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
88:6848	NULL
,	NULL
1991	NULL
37	NULL
.	NULL

Busque	NULL
L	NULL
,	NULL
Zhu	NULL
J	NULL
,	NULL
DeHart	NULL
D	NULL
,	NULL
Griffith	NULL
B	NULL
,	NULL
Willman	NULL
C	NULL
,	NULL
Carroll	NULL
R	NULL
,	NULL
McBlack	NULL
P	NULL
,	NULL
Gilliland	NULL
DG	NULL
:	NULL
An	NULL
expression	NULL
based	NULL
clonality	NULL
assay	NULL
at	NULL
the	NULL
human	NULL
androgen	NULL
receptor	NULL
locus	NULL
(	NULL
HUMARA	NULL
)	NULL
on	NULL
chromosome	NULL
X.	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
22:697	NULL
,	NULL
1994	NULL
38	NULL
.	NULL

Adams	NULL
RLP	NULL
,	NULL
Knowler	NULL
JT	NULL
,	NULL
Leader	NULL
DP	NULL
:	NULL
The	NULL
Biochemistry	NULL
of	NULL
the	NULL
Nucleic	NULL
Acids	NULL
.	NULL

London	NULL
,	NULL
UK	NULL
,	NULL
Chapman	NULL
and	NULL
Hall	NULL
,	NULL
1986	NULL
39	NULL
.	NULL

Gale	NULL
RE	NULL
,	NULL
Wheedon	NULL
H	NULL
,	NULL
Linch	NULL
DC	NULL
:	NULL
X	NULL
chromosome	NULL
inactivation	NULL
patterns	NULL
using	NULL
HPRT	NULL
and	NULL
PGK	NULL
polymorphisms	NULL
in	NULL
haematologically	NULL
normal	NULL
and	NULL
post-chemotherapy	NULL
females	NULL
.	NULL

Br	NULL
J	NULL
Haematol	NULL
79:193	NULL
,	NULL
1991	NULL
40	NULL
.	NULL

Gale	NULL
RE	NULL
,	NULL
Wainscoat	NULL
JS	NULL
:	NULL
Clonal	NULL
analysis	NULL
using	NULL
X-linked	NULL
DNA	NULL
polymorphisms	NULL
.	NULL

Br	NULL
J	NULL
Haematol	NULL
85:2	NULL
,	NULL
1993	NULL
41	NULL
.	NULL

Busque	NULL
L	NULL
,	NULL
Gilliland	NULL
DG	NULL
:	NULL
Clonal	NULL
evolution	NULL
in	NULL
acute	NULL
myeloid	NULL
leukemia	NULL
.	NULL

Blood	NULL
82:337	NULL
,	NULL
1993	NULL
42	NULL
.	NULL

Anger	NULL
B	NULL
,	NULL
Janssen	NULL
JWG	NULL
,	NULL
Schrezenmeier	NULL
H	NULL
,	NULL
Hehimann	NULL
R	NULL
,	NULL
Heimpel	NULL
H	NULL
,	NULL
Bartram	NULL
CR	NULL
:	NULL
Clonal	NULL
analysis	NULL
in	NULL
chronic	NULL
myeloproliferative	NULL
disorders	NULL
using	NULL
X-linked	NULL
DNA	NULL
polymorphisms	NULL
Leukemia	NULL
4:258	NULL
,	NULL
1990	NULL
43	NULL
.	NULL

Lucas	NULL
GS	NULL
,	NULL
Padua	NULL
RA	NULL
,	NULL
Masters	NULL
GS	NULL
,	NULL
Oscier	NULL
DG	NULL
,	NULL
Jacobs	NULL
A	NULL
:	NULL
The	NULL
application	NULL
of	NULL
X	NULL
chromosome	NULL
gene	NULL
probes	NULL
to	NULL
the	NULL
diagnosis	NULL
of	NULL
myeloproliferative	NULL
disease	NULL
.	NULL

Br	NULL
J	NULL
Haematol	NULL
72:530	NULL
,	NULL
1989	NULL
44	NULL
.	NULL

Taylor	NULL
KM	NULL
,	NULL
Shetta	NULL
M	NULL
,	NULL
Talpaz	NULL
M	NULL
,	NULL
Kantarjian	NULL
HM	NULL
,	NULL
Hardikar	NULL
S	NULL
$	NULL
,	NULL
Chinault	NULL
AC	NULL
,	NULL
McCredie	NULL
KB	NULL
,	NULL
Spitzer	NULL
G	NULL
:	NULL
Myeloproliferative	NULL
disorders	NULL
:	NULL
Usefulness	NULL
of	NULL
X-linked	NULL
probes	NULL
in	NULL
diagnosis	NULL
.	NULL

Leukemia	NULL
3:419	NULL
,	NULL
1989	NULL
45	NULL
.	NULL

Asimakopoulos	NULL
FA	NULL
,	NULL
Holloway	NULL
TL	NULL
,	NULL
Nacheva	NULL
EP	NULL
,	NULL
Scott	NULL
MA	NULL
,	NULL
Fenaux	NULL
P	NULL
,	NULL
Green	NULL
AR	NULL
:	NULL
Detection	NULL
of	NULL
chromosome	NULL
20q	NULL
deletions	NULL
in	NULL
bone	NULL
marrow	NULL
metaphases	NULL
but	NULL
not	NULL
peripheral	NULL
blood	NULL
granulocytes	NULL
in	NULL
patients	NULL
with	NULL
myeloproliferative	NULL
disorders	NULL
or	NULL
myelodysplastic	NULL
syndromes	NULL
.	NULL

Blood	NULL
87:1561	NULL
,	NULL
1996	NULL
46	NULL
.	NULL

Tsukamoto	NULL
N	NULL
,	NULL
Morita	NULL
K	NULL
,	NULL
Machara	NULL
T	NULL
,	NULL
Okamoto	NULL
K	NULL
,	NULL
Sakai	NULL
H	NULL
,	NULL
Karasawa	NULL
M	NULL
,	NULL
Naruse	NULL
T	NULL
,	NULL
Omine	NULL
M	NULL
:	NULL
Clonality	NULL
in	NULL
chronic	NULL
myeloproliferative	NULL
disorders	NULL
defined	NULL
by	NULL
X	NULL
chromosome	NULL
linked	NULL
probes	NULL
:	NULL
Demonstration	NULL
of	NULL
heterogeneity	NULL
in	NULL
lineage	NULL
involvement	NULL
.	NULL

Br	NULL
J	NULL
Haematol	NULL
86:253	NULL
,	NULL
1994	NULL
47	NULL
.	NULL

Tan	NULL
SS	NULL
,	NULL
Williams	NULL
EA	NULL
,	NULL
Tam	NULL
PPL	NULL
:	NULL
X-chromosome	NULL
inactivation	NULL
occurs	NULL
at	NULL
different	NULL
times	NULL
in	NULL
different	NULL
tissues	NULL
of	NULL
the	NULL
postimplantation	NULL
mouse	NULL
embryo	NULL
.	NULL

Nature	NULL
Genet	NULL
3:170	NULL
,	NULL
1993	NULL
48	NULL
.	NULL

Gale	NULL
RE	NULL
,	NULL
Wheadon	NULL
H	NULL
,	NULL
Boulos	NULL
B	NULL
,	NULL
Linch	NULL
DC	NULL
:	NULL
Tissue	NULL
specificity	NULL
of	NULL
X	NULL
chromosome	NULL
inactivation	NULL
patterns	NULL
.	NULL

Blood	NULL
83:2899	NULL
,	NULL
1994	NULL
49	NULL
.	NULL

Hughes	NULL
A	NULL
:	NULL
Optimization	NULL
of	NULL
microsatellite	NULL
analysis	NULL
for	NULL
genetic	NULL
mapping	NULL
.	NULL

Genomics	NULL
15:433	NULL
,	NULL
1993	NULL

